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The human brain predominantly relies on oxidative metabolism of glucose to meet its enormous energy
requirements. The total amount of energy consumed by the brain can be indirectly measured by quantifying
global cerebral metabolic rate of oxygen consumption (CMRO2). CMRO2 is known to be closely related to
neuronal functioning and hence can serve as an important marker of brain vitality and health. Accurate
absolute CMRO2 quantification would enable detailed investigation of the neuro-metabolic-hemodynamic
relationships underlying cerebral activation and pathology.
Despite the considerable utility and importance of determining absolute CMRO2, a robust and reliable
method adaptable to clinical and functional applications is lacking. We propose a method for simultaneous
measurement of cerebral blood flow (CBF) and venous oxygen saturation (SvO2) with a high temporal
resolution (&sim30s at 3T). The former is quantified by using phase contrast MRI and the latter by MR
susceptometry based oximetry. Fick's first law is used to determine CMRO2 from the above two parameters.
This thesis first explored the feasibility of using the proposed methodology for in-vivo CMRO2 quantification
and tested the validity of the underlying model assumptions. The hemodynamic and metabolic measurements
obtained in-vivo agreed well with previous literature results. Next, the accuracy of the proposed MR
susceptometry based oximetry was evaluated against the clinically established gold standard (co-oximetry
measurements) and the two methods showed excellent agreement. Further the sensitivity of the proposed
method to detect physiologically expected changes in response to a stimulus (hypercapnia) was examined. In
line with the known vasodilatory effect of hypercapnia, an increase in CBF and SvO2 was observed. However,
no statistically significant change in CMRO2 was noted.
The method was then translated clinically in small pilot studies to investigate neonates with congenital heart
disease (CHD) and adolescents with sickle cell disease (SCD). In the CHD study, the MR measured
hemodynamic parameters were cross validated with optical measurements and a significant association
between post-operative CMRO2 and brain injury was observed. In the SCD study, chronic transfusions were
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of these illnesses with implications for clinical management paradigms.
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on complex difference subtraction of velocity encoded projections and unlike susceptometry based oximetry
is not restricted by the vessel orientation with respect to main magnetic field or the need for surrounding
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Abstract 
MRI BASED QUANTIFICATION OF GLOBAL CEREBRAL 
METABOLISM 
Varsha Jain 
Felix W. Wehrli, Ph.D 
 
The human brain predominantly relies on oxidative metabolism of glucose to 
meet its enormous energy requirements. The total amount of energy consumed by the 
brain can be indirectly measured by quantifying global cerebral metabolic rate of oxygen 
consumption (CMRO2). CMRO2 is known to be closely related to neuronal functioning 
and hence can serve as an important marker of brain vitality and health. Accurate 
absolute CMRO2 quantification would enable detailed investigation of the neuro-
metabolic-hemodynamic relationships underlying cerebral activation and pathology. 
 Despite the considerable utility and importance of determining absolute CMRO2, 
a robust and reliable method adaptable to clinical and functional applications is lacking. 
We propose a method for simultaneous measurement of cerebral blood flow (CBF) and 
venous oxygen saturation (SvO2) with a high temporal resolution (~30s at 3T). The former 
is quantified by using phase contrast MRI and the latter by MR susceptometry based 
oximetry. Fick’s first law is used to determine CMRO2 from the above two parameters. 
 This thesis first explored the feasibility of using the proposed methodology for in-
vivo CMRO2 quantification and tested the validity of the underlying model assumptions. 
The hemodynamic and metabolic measurements obtained in-vivo agreed well with 
previous literature results. Next, the accuracy of the proposed MR susceptometry based 
oximetry was evaluated against the clinically established gold standard (co-oximetry 
measurements) and the two methods showed excellent agreement. Further the sensitivity 
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of the proposed method to detect physiologically expected changes in response to a 
stimulus (hypercapnia) was examined. In line with the known vasodilatory effect of 
hypercapnia, an increase in CBF and SvO2 was observed. However, no statistically 
significant change in CMRO2 was noted.  
The method was then translated clinically in small pilot studies to investigate 
neonates with congenital heart disease (CHD) and adolescents with sickle cell disease 
(SCD). In the CHD study, the MR measured hemodynamic parameters were cross 
validated with optical measurements and a significant association between post-operative 
CMRO2 and brain injury was observed. In the SCD study, chronic transfusions were 
associated with lower cerebral blood flows and oxygen extraction fractions.  Both of 
these populations are at significant risk for cerebral ischemia, thus making quantification 
of cerebral hemodynamic and metabolic parameters valuable. Additional insights gained 
would provide greater understanding of the pathophysiology of these illnesses with 
implications for clinical management paradigms. 
 Lastly, we explored a quick T2 based method for determining oxygen saturation 
of blood. The method relies on complex difference subtraction of velocity encoded 
projections and unlike susceptometry based oximetry is not restricted by the vessel 
orientation with respect to main magnetic field or the need for surrounding reference 
tissue. The method demonstrated sensitivity to oxygenation differences between different 
cerebral territories (cortex vs. deep brain) as well as in response to a hypercapnic 
stimulus.  
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Chapter 1: Background and Significance 
 
1.1 CMRO2 and the Brain 
1.1.1 Appraising Brain’s Energy Budget 
The human brain is one of the most oxygen hungry organs in the body as it relies 
predominantly on aerobic metabolism of glucose to meet its energy requirements. Even 
though it accounts for only 2% of total body weight, it utilizes 20% of total oxygen and 
hence calories consumed by the body [1]. Within normal levels of cerebral blood flow 
(CBF) the brain extracts about 30-50% of oxygen from arterial blood. This high rate of 
metabolism is remarkably constant over time despite widely varying mental and motor 
activities [2]. This ongoing metabolic activity consists largely of oxidation of glucose to 
carbon dioxide and water, resulting in the production of large amounts adenosine 
triphosphate (ATP) (Equation 1.1).  These high-energy phosphates are the most important 
energy source for the brain.   
            6O2 + C6H12O6 + 36ADP + 36Pi    36ATP + 6CO2 + 6H2O         [1.1] 
An appraisal of the brain’s energy budget indicates that most of this energy 
(~80%) is required for the propagation of action potentials and for restoring postsynaptic 
ion fluxes after the receptors have been stimulated by the neurotransmitters. In contrast, 
maintenance of the resting potential in neurons and glial cells accounts for less than 15% 
of the total energy consumption [3-5]. An intriguing body of recent research has shown 
that even in the resting state, a delicate balance between synaptic excitatory and 
inhibitory activity exists and a large amount of cerebral energy resources are devoted to 
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maintain this equilibrium [6-7]. Thus, even in the “non-activated” resting state the brain 
is very “active”. 
A good way to quantify this “activity” and therefore the brain’s energy demands 
is to measure the rate at which the brain metabolizes oxygen. This is known as cerebral 
metabolic rate of oxygen consumption (CMRO2). CMRO2 has been shown to be closely 
related to neuronal functioning and hence can serve as an important marker of brain 
vitality and health. In addition, its quantification can enable detailed investigation of the 
neuro-metabolic-hemodynamic relationships underlying cerebral activation and 
pathology. 
 
1.1.2 Quantification of CMRO2 
In order to meet its energy requirements the brain relies on oxygen delivery 
through the blood. Oxygen present in the atmosphere diffuses into the pulmonary 
capillaries through the alveoli (air sacs) in the lungs. The diffused oxygen is bound to 
hemoglobin in the red blood cells. After oxygenation blood moves into the pulmonary 
veins which drain into the left side of the heart. Oxygenated blood is then pumped into 
the systemic circulation via the aorta. The brain receives blood from two main sources: 
the internal carotid arteries and the vertebral arteries. These arteries then break down to 
smaller arteries, arterioles and then capillaries. Facilitated by oxygen diffusion gradients, 
oxygen is delivered to the brain and oxygen poor blood is returned to the venous 
circulation. Venous blood is then returned to the lungs for re-oxygenation and the cycle 
continues. Assuming all of the oxygen extracted in this process is consumed by the brain 
cells for energy production, Fick’s first law can be applied to relate CMRO2 to arterio-
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venous oxygen saturation difference (AVO2D = SaO2 –SvO2) and oxygen delivery via 
cerebral blood flow (CBF) as 
   222 OSOSCBFCCMRO vaa                                [1.2] 
where Ca is the concentration of O2 in moles per 100mL of blood and Sa/vO2 represents 
the arterial/venous oxygen saturation. 
 
1.1.3 Importance of Measuring Global CMRO2 
A method for quantifying whole brain CMRO2 can provide valuable insights into 
global neuronal activity during various stimuli, such as breathing of gas mixtures 
containing variable concentrations of physiological gases, sleep, anesthesia, hypothermia, 
drugs etc. Understanding the effects of hypercapnia, hypoxemia or hyperoxia on cerebral 
metabolism is of considerable interest to the basic science community. These stimuli are 
used for normalizing blood oxygen-level dependent (BOLD) response in functional 
magnetic resonance imaging (fMRI) under the assumption that the breathing of these gas 
mixtures does not alter global CMRO2 [8-9]. However, considerable disagreement exists 
in the literature regarding the metabolic effects of these gas mixtures [10 , 11-14]. More 
interestingly, the metabolic implications of these stimuli might vary from normal under 
certain pathological conditions. For example, in situations where oxygen delivery is 
limited either due to poor perfusion or low oxygen carrying capacity of blood, a strong 
vasodilatory stimulus such as hypercapnia might be therapeutic and have a positive effect 
on cerebral metabolism. As part of this thesis we have explored the effect of hypercapnia 
in one such population, neonates with congenital heart disease. 
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Absolute in vivo quantification of global CMRO2 may also have profound 
implications on understanding the effect of many pathologic conditions on brain 
metabolism and physiology. For example, a comparison of the cerebral metabolism in 
various systemic disease conditions (such as congenital heart disease and sickle cell 
disease), in response to an intervention (cardiac surgery, blood transfusions) or against 
healthy controls can provide further insights into the mechanisms underlying neuronal 
injury.  
Quantifying CMRO2 by invoking Fick’s principle has an additional advantage that 
one can use CBF information to study the state of neurovascular coupling in conditions 
such as hypertension, Alzheimer’s dementia, etc. In these pathologies, the tight 
interaction between neural activity and cerebral blood flow is disrupted, and the resulting 
homeostatic imbalance is suspected to contribute to brain dysfunction.  
 
1.2 Methods for Measuring CMRO2 
Several methods for determining CMRO2 exist. They can be broadly classified as non-
MR and MR based methods.  
 
1.2.1 Non-MR Methods 
Jugular bulb oximetry and Transcranial Doppler Ultrasound 
This method represents some of the earliest attempts to measure cerebral 
metabolism. In jugular bulb oximetry fiber-optic catheters are used to determine venous 
oxygenation [15-17]. CBF is usually determined using transcranial Doppler (TCD) 
ultrasound. 
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A major advantage of the method is that it is amenable to continuous bedside 
monitoring of cerebral oxygenation and metabolism. However, the method is fraught 
with technical challenges. The catheter has to be calibrated before and after insertion and 
thereafter every few hours by drawing a blood sample from the catheter and measuring 
the oxygen saturation on a co-oximeter. Additionally, the reflected light intensity of the 
fiber-optic device has to be checked regularly as it is dependent on the correct placement 
of the catheter tip within the lumen. If the catheter becomes attached to the wall of the 
vein reflected light intensity will be reduced. A previous study by Sheinberg et al. found 
that almost 50% of readings that suggested desaturation were incorrect [18], usually as a 
result of low light intensity. Additionally, because of the invasive nature of the technique, 
it is prone to complications such as carotid artery puncture (incidence 1% to 4.5%), 
hematoma formation, jugular vein occlusion, thrombosis, and a risk of bacteremia and 
other infections [19]. 
Transcranial Doppler (TCD) sonography was first introduced in 1982 by Aaslid, 
Markwalder and Nornes [20]. Using a 2 MHz pulsed Doppler it is possible to penetrate 
the skull at certain areas and to record the blood flow velocity from major basal cerebral 
arteries. The most frequent measurement site is transtemporal, where the middle cerebral 
artery, internal carotid artery and anterior cerebral artery can be identified [21]. Vessel 
identification depends on the cranial window used, the depth of the sample volume, the 
flow direction and the spatial relationships of vessels. The mean velocity as measured by 
TCD is the time averaged maximum velocity during the cardiac cycle. However, blood 
flow velocity does not give direct information on CBF and estimation of vessel cross 
sectional area is challenging using ultrasound due to poor spatial resolution.   
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Near Infrared Spectroscopy 
Near-infrared spectroscopy (NIRS) is yet another method for measuring cerebral 
oxygenation continuously by the bedside. The technique permits the measurement of 
hemoglobin saturation at distances of up to several centimeters below the tissue surface. 
Near-infrared light with a wavelength between 650–1100 nm can penetrate the scalp, 
skull and brain [21-22]. Oxyhemoglobin and deoxyhemoglobin absorb near-infrared light 
at different wavelengths. Their corresponding absorption spectra can be used to estimate 
relative concentrations of oxy/deoxyhemoglobin. However, no separation between 
arterial, venous or capillary compartments in the measured brain areas can be discerned. 
Additionally, the method suffers from adverse effects related to the skull, cerebrospinal 
fluid, myelin sheaths, ambient light, etc. [23]. At present, NIRS is more reliable in 
neonates than in adults.  
Diffuse correlation spectroscopy (DCS) is another optical technique that can be 
used to measure relative changes in cerebral blood flow [24-25]. Like NIRS, DCS also 
employs near-infrared light to probe the dynamics of deep tissues. It directly measures 
the motion of the scatterers, which in the case of biological tissues are the red blood cells. 
The dynamic or correlation method measures flow by using coherent light sources and 
monitoring the temporal statistics of the speckle fluctuations of the scattered light. It is 
noted that both of the above mentioned methods (NIRS and DCS) provide information 
about microvascular hemodynamics over a focal region under the optical probe. The 
above two measurements can be combined to infer information about changes in regional 
CMRO2 (using Fick’s equation).  
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Intracerebral Microdialysis 
The intracerebral microdialysis (MD) technique was introduced for long-term 
monitoring of brain energy metabolism in patients with acute brain injuries [26]. The 
method enables the retrieval and analysis of small molecules present in the extracellular 
fluid (ECF); these include metabolism-related compounds (lactate, pyruvate, glucose, 
adenosine, inosine, and hypoxanthine) and excitatory amino acids (EAAs) (glutamate and 
aspartate). These products are retrieved using microdialysis probes implanted during 
surgery or with an intracranial pressure (ICP) monitoring device.  
The first clinical experience of MD in a human brain was performed in the frontal 
cortex adjacent to a glioma during lobectomy; this served as a model of ischemia [27]. 
Another study by Persson et al. correlated alterations in dialysate levels with 
ischemic/hypoxic events assessed clinically during neurosurgical intensive care (NIC) 
[26]. Further work by Enblad et al. [28] demonstrated agreement between MD and PET 
based measurements of CMRO2, supporting the hypothesis that the ECF substances 
retrieved by MD can be used as “markers” of cerebral metabolism and ischemia. 
However, a clear disadvantage of the method is its very invasive nature. 
 
Positron Emission Tomography 
Positron emission tomography (PET) has been the method of choice for 
quantitative in vivo estimation of CBF, OEF and CMRO2 [29-30]. Measurement of 
regional CBF using PET involves introduction, usually via an intravenous injection, of 
radioactive O-15 tracer into the human body. CMRO2 can be measured using an 
inhalation of O-15 labeled oxygen with air. This radioactive form of oxygen binds to 
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hemoglobin and is converted to O-15 water after oxidative metabolic consumption 
(Equation 1.1). The radioactive tracer emits positrons, and the emitted positrons undergo 
annihilation upon contact with electrons from its surroundings. This process produces 
two photons of equal energy (511 keV) in opposite directions which are detected by the 
PET detectors. The data gathered from the coincidence events and “lines of response” is 
used to determine the source of positron annihilation at a given time and converted into a 
tomographic image. Other tracers are available to illustrate additional brain functions that 
investigators may be interested in studying.  
In recent years, PET has been used to study cerebral metabolism in several 
clinical disorders such as dementia, brain tumors, psychiatric disease, epilepsy, 
movement disorders and stroke, as well as in normal states such as aging [31-35]. OEF 
measurements using PET have been validated in primates using intra-carotid injections of 
O-15 labeled oxygen [36-37]. It is, however, restrictive in terms of its utility due to the 
high radiation dose, relatively complex setup required for the constant delivery of radio-
labeled gases, high associated expenses, and long scan times during which it is assumed 
that no change in the physiologic state occurs. Additionally, the anatomical resolution of 
detail is quite limited (~about 0.5 cm3). 
 
1.2.2 MR based Methods 
Recent years have seen increased use of MRI in biomedical imaging research as 
well as in clinical diagnostics and decision making. As compared to other medical 
imaging modalities such as Computed Tomography (CT), PET and Ultrasound MRI 
offers superior sensitivity to a wide range of tissue properties and is completely non-
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invasive. In addition to providing anatomic information, MRI has demonstrated to be a 
promising modality for functional and metabolic imaging as well.  The discovery of 
blood oxygenation level dependent (BOLD) effect was a significant step forward in this 
direction. The BOLD signal strength depends on the concentration of deoxyhemoglobin. 
Several studies have since used this contrast mechanism to detect relative hemodynamic 
alterations in the brain in response to functional activation tasks (in comparison to a 
resting state) and these experiments have become popular as functional MRI (fMRI). 
However, since the BOLD response represents the end product of a complex interplay 
between CBF, cerebral blood volume (CBV) and CMRO2, fMRI experiments do not 
provide specific and absolute information about baseline oxygen metabolism.  
Most MR based absolute methods (as discussed in this thesis) determine CMRO2 
as a product of CBF and AVO2D by invoking Fick’s principle (Eq.1.2). Several well 
validated MR based techniques for quantifying CBF, both in micro as well as macro 
vessels exist, such as arterial spin labeling (ASL), phase contrast velocity mapping or 
dynamic susceptibility contrast (DSC). The challenge is measuring venous oxygen 
saturation for quantifying AVO2D. Three broad categories of methods exist for measuring 
venous oxygen saturation using MR: (1) phase-based susceptibility methods (2) 
intravascular T2 based methods and (3) extravascular T2’ based methods. All these 
methods rely on the paramagnetic behavior of deoxygenated hemoglobin in an external 
magnetic field.    
Blood is composed of plasma, red blood cells (RBC’s), white blood cells and 
platelets. RBC’s contain oxy- (Hb bound with oxygen) and deoxyhemoglobin (dHB 
without oxygen). First reports of different magnetic behavior of oxy and deoxy-
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hemoglobin date back to seminal experiments by Pauling and Coryell in 1936 using a 
magnetic mass balance that measured the force exerted by the interaction of the sample’s 
magnetization with a gradient magnetic field [38].  The reason for this observed 
difference is the change in the electronic structure of the heme iron in a hemoglobin 
molecule upon oxygenation. In the oxygenated state the five energetically split e2g and 
t2g orbitals in 3d orbital of iron move apart making electron pairing in the lower energy 
t2g orbitals more energetically favorable (low spin state) relative to the deoxy state where 
electrons occupy all five 3d orbitals (high spin state). This transition from a low-spin 
state in oxyhemoglobin to a high-spin state in deoxyhemoglobin accounts for the former 
being diamagnetic and the latter paramagnetic.  
 
 Phase based Susceptibility Methods  
Variations in the magnetic susceptibility of component elements of a tissue cause 
perturbations in a magnetic field. While the inverse problem, i.e. inferring the 
susceptibility of an arbitrarily shaped object given a field distribution is an ill-posed one, 
fortunately analytical solutions exist for simple geometries such as spheres and long 
cylinders. Most of the large blood vessels can be modeled as long cylinders; where radius 
is much smaller than the length. In the infinite length limit, the susceptibility calculation 
becomes a two-dimensional problem and can be solved by assuming simple boundary 
conditions and dipolar field distributions. The induced field takes on different constant 
values inside and outside the cylinder. In the limit of small susceptibility, ||<<1, which is 
valid for most biological materials, field shifts due to local susceptibility variations can 
be approximated as 
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where 0BBB
  ,  is the variation in susceptibility, a is the vessel radius, 
22 yx  is the distance from the center of the vessel,   is the vessel tilt relative to 
B0 field and   is the polar angle in x-y plane of the observation point relative to the 
external field (Figure 1.1). 
However, Bin as represented above represents only part of the effective (or 
measurable) local field. A subtle but sizable effect arises because susceptibility cannot be 
considered continuous inside 
compartments such as biological blood 
vessels. The atomic or molecular 
‘granularity’ leads to cancellation of fields 
from nearby molecules. This is 
called the ‘Lorentz sphere’ phenomenon. 
 
 
 
 
 
Figure 1.1: The long infinite cylinder model for MR-susceptometry measurements. 
The cylinder lies in x-z plane at an angle   to the external B0 field. 
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This molecular demagnetization due to Lorentz sphere correction reduces the field inside 
the cylinder by 03
2 B . Thus, the net induced field inside the cylinder becomes, 
                                                1cos3
6
2
0   BBin                        [1.5]     
In an actual MR experiment these field changes due to variations in susceptibility 
result in a phase change (inside relative to outside the vessel ; ) of the MR signal at the 
acquisition (echo) time TE and is expressed as 
                                                        TEB                                        [1.6] 
 A single acquisition at time TE would be sufficient to calculate the susceptibility of an 
object if there were no background phase offsets. When gradients are turned on and off, 
there are often transient field effects. Additionally, it is known that the RF response of an 
object depends on its local conductivity and has a direct effect on the phase of the MR 
signal. These variations in local conductivity can be shown to induce a constant phase 
offset 0 independent of time. Thus, phase difference between two gradient echoes is 
preferable as it can subtract out this phase offset. 
The final step is to now relate the calculated susceptibility value of blood to its 
oxygenation status.  One can use Cerdonio’s [39] whole blood susceptibility model to 
determine magnetic susceptibility as a function of oxygenation: 
    plasmadeoxyoxyWB HctYHctYHct   11            [1.7] 
where Hct is the fraction by volume taken up by the red blood cells, Y  is the oxygenation 
level of blood, and WB, oxy, deoxy and plasma represents the volume susceptibilities of 
whole blood, oxygenated and deoxygenated red blood cells and plasma, respectively.  
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The actual imaging experiment does not measure WB directly, but rather measures 
WB with respect to surrounding tissue (in vivo) or water (ex-vivo). Additionally, previous 
work has shown that the susceptibility of plasma and water are identical (within 
experimental noise) and hence plasma can be replaced by water in the above expression 
(Eq. 1.6). This approximation works well for in-vivo applications as well since most 
tissues are comprised primarily of water (~80%) [40]. Hence, the above expression can 
be re-written as, 
  oxydoWB YHct   1      [1.8] 
where WB, do and oxy represent the susceptibility difference between whole blood 
and water/tissue, fully oxygenated and deoxygenated blood, and oxygenated blood and 
water/tissue. By combining equations 1.5 and 1.8, the expression below relates blood 
oxygenation level (HbO2 ) to the phase difference between the intra and extra-vascular 
MR signal () over a period TE 
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Haacke et al. used a velocity compensated gradient echo sequence to determine 
venous oxygenation at rest and in a functionally activated state in small pial veins in the 
brain [41]. Additionally they measured flow changes in the same pial vein in response to 
functional activation. Assuming negligible change in CMRO2 in response to simple 
functional tasks, they observed excellent agreement between calculated (using Fick’s 
equation, Equation 1.2) and observed changes in venous oxygenation. Fernandez-Seara et 
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al. used a similar approach to measure venous oxygenation in the internal jugular veins 
during rest, breath-holding and hypoventilation [42].  
In these applications the vessels of interest (pial and jugular veins) were modeled 
as long infinite paramagnetic cylinders parallel to the Bo field with homogenous field 
inside the vessel and a vanishing field outside (=0; refer to equations 1.4 and 1.5). 
However, in reality significant deviations from the cylindrical approximation can occur 
as vessels tilt, taper, branch, curve and assume noncircular cross-section. In chapter 2 we 
explore the validity of the cylindrical approximation for non-circular prism shaped 
phantoms to apply the method to measure oxygenation in superior sagittal sinus. 
Additional simulation based work by Cheng et al. [43] using actual vessel geometries has 
shown that the cylinder approximation works well for several in-vivo vessels (jugular 
vein, femoral vein and superior sagittal sinus) despite the afore-mentioned deviations in 
vessel geometry; vessel tilts as high as 30 introduced an error of less than 5% 
HbO2.While the signal model assumes a long infinite cylinder, previous work on femoral 
vessels in vivo revealed that the approximation is valid for length to diameter ratio as low 
as 6 [44]. Thus the method is well suited for in-vivo applications. 
Unlike T2 based methods (discussed below), phase based methods do not need an 
ex vivo calibration curve and a simple linear relationship between phase and oxygenation 
exists. However, both the above investigations had relatively long acquisition times (~2 - 
4 mins). In this thesis we have explored high temporal resolution oxygenation 
measurements with simultaneous blood flow measurements in order to compute CMRO2 
(using Fick’s equation).  
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Intravascular T2 based Methods 
Dependence of T2 relaxation on the oxygenation state of blood has been observed 
widely and several groups have explored the underlying mechanisms via simulations and 
ex vivo MR studies [45-53]. It is now generally agreed that relaxation occurs as protons 
diffuse through varying magnetic field gradients induced by the erythrocytes. These field 
gradients are established as a result of frequency shifts between intra- and extra- 
erythrocyte spaces due to the paramagnetism of deoxyhemoglobin. Protons randomly 
experience a range of different frequencies as they move through the local field gradients 
surrounding the erythrocytes causing relaxation. This relaxation process can be generally 
modeled as, 
                                                  exRRR ,20,22     [1.10] 
where R2 is the measured relaxation rate, R2,0 is the R2 of fully oxygenated blood and R2, 
ex is the enhanced relaxation rate due to exchange or diffusion. R2,0 has been previously 
illustrated to be a weighted sum of the relaxation rates of various blood components [54], 
namely erythrocytes and plasma, and can be expressed as: 
 
RBCplasma RHctRHctR ,2,20,2 )1(     [1.11] 
where  
  deoxyoxydiaplasmaRBC RHbORHbORRR ,22,22,2,2,2 1   
 
and “plasma”, “dia”, “oxy” and “deoxy” refer to plasma, intrinsic diamagnetic, 
oxygenated and deoxygenated hemoglobin contributions, respectively, and HbO2 
represents the blood oxygenation level.  
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R2,ex  is a more complicated parameter and is dependent on the acquisition scheme 
used to determine T2. Specifically, some variation of multi-spin-echo Carr-Purcell 
Meiboom-Gill (CPMG) sequence is typically used to determine T2 and R2,ex which 
represents relaxation enhancement due to diffusion mediated dephasing dependent on the 
time delay between two consecutive 180 pulses in the CPMG sequence, represented as 
cp. If cp is short compared to the exchange time (ex) (between the frequency shifted 
sites), dephasing will be minimal due to quick refocusing between the spin echoes. 
However if cp is long relative to ex , many protons will move/diffuse between the sites if 
not refocused, leading to maximal dephasing. Theoretically, a maximum value of cp 
exists beyond which the R2 enhancement cannot increase, as protons will by this point 
have experienced a full range of field variations and so are fully dephased [48].  
The exact theoretical expression to relate the dependencies of R2,ex on various parameters  
depends on the biophysical model employed, e.g. rapid exchange or diffusion model. 
While there is no consensus on which model most accurately describes the observed 
relaxation process, in most models R2,ex is expressed as a function of  cp, ex, Hct, HbO2, 
 (coefficient related to the geometry of the erthryocytes) and B0 field.  The echo 
generated from a Carr-Purcell-Meiboom-Gill (CPMG) sequence, for example, can be 
described on the basis of the Luz-Meiboom model that invokes exchange of spins 
between two sites differing in resonance frequencies as [46, 55]: 
  


 
ex
cp
cp
ex
exAA HbOPPRR 



2
tanh21)1()1( 2020,22  [1.12] 
where PA is the fraction of protons residing at one of the sites of exchange. 
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Based on the above equation, Wright et al. [46] proposed an ex vivo calibration 
method to compute oxygen saturation without utilizing the exact knowledge of all 
parameters, by absorbing them into a single parameter K (a function of cp,ex, 0,  and 
PA) and leaving out (1-HbO2)2. 
                                            220,22 1 HbOKRR       [1.13] 
They then derived a calibration curve between T2 and HbO2 using ex-vivo blood samples 
at various oxygen saturation values. Assuming that K is identical between ex vivo and in 
vivo conditions, the calibration curve was used to determine in vivo oxygen saturation 
levels in superior vena cava, aorta and pulmonary arteries. This was truly a landmark 
study and has since inspired several investigations. One of these is a method called T2 
Relaxation Under Spin Tagging (TRUST) [53]. This method employs subtraction of 
“control” and “label” scans, similar to ASL, to isolate pure venous signal and suppress 
background static tissue. Hence, it is robust against partial volume effects. T2 of venous 
blood is measured by fitting the signal obtained, using a variable number of refocusing 
pulses, to an exponential decay model. Recently, Xu et al. combined the TRUST method 
with phase contrast MRI to measure venous oxygenation in superior sagittal sinus and 
cerebral blood flow in major inflow arteries (internal carotid and vertebral arteries) to 
quantify CMRO2 [56].  
The major advantage of T2 based methods is their robustness against background 
field in-homogeneities. However, due to a complicated signal relationship between T2 
and HbO2, an ex-vivo calibration curve is necessary. This curve is specific for the 
sequence used to obtain it, the field strength and the blood chemistry (such as pH, Hct 
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etc.). Here, calibration might be challenging under pathological conditions where 
physiological parameters might deviate significantly from their normal values. 
 
Extravascular T2’ based Methods 
T2’ based methods rely on the extravascular spin dephasing caused by 
intravascular paramagnetic sources (deoxyhemoglobin). An important assumption 
underlying the method is that the system is in the static dephasing regime. This means 
that in an FID experiment, NMR signal dephasing due to susceptibility induced field 
inhomogeneities should have occurred before molecular diffusion averages out the phase 
accumulated by different nuclear magnetic moments. By modeling the microvasculature 
in the brain as a network of randomly oriented paramagnetic cylinders, Yablonskiy and 
Haacke proposed an analytical model to characterize the MR signal alterations in the 
static dephasing regime [57].  
However, the MR signal expression is quite complicated and for computational 
purposes can be expressed using two asymptotic forms; a short time scale and a long time 
scale form. The long time scale expression relates the signal equation as a function of 
R2’. Theoretically, R2’ (=R2*-R2) is the relaxation rate that characterizes the signal loss 
caused by local susceptibilities and is expressed as 
                                                           2R     [1.14] 
where 
02 )1(3
4 BHbOHctdo    
and  is the volume fraction of the cylinders/blood vessels. 
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In an actual experiment, hybrid spin echo and gradient multi-echo sequences (e.g. 
gradient echo sampling of spin echo (GESSE)) are used where R2’ is estimated by 
removing the effect of R2 from the net signal collected.  
The MR signal is a Gaussian function at short time scales and mono-exponential 
at longer time scales. The model establishes a direct relationship between the 
susceptibility variations and the MR measured signal. The close form signal description, 
which is approximated by two asymptotic forms, can be used to estimate the volume 
fraction of susceptibility sources as well as the absolute susceptibility. 
An et al. used this method to estimate regional cerebral oxygen saturation in 
normal human subjects [58]. They assumed a single compartment model (i.e. 
extravascular tissue was considered as the sole source of MR signal and additional 
contributions due to blood or cerebrospinal fluid (CSF) were ignored). Using this 
approach, they generated regional oxygen extraction fraction (OEF= 1-SvO2/SaO2) and 
CMRO2 maps. He and Yablonskiy refined the method further by considering a multi-
compartment model, which included the effect of blood and CSF on the MR signal [59]. 
This updated approach was called quantitative BOLD (qBOLD), and has been validated 
in a rat model where cerebral venous oxygenation was manipulated under anesthesia and 
qBOLD measurements were compared with direct blood draws from the superior sagittal 
sinus [60]. 
Unlike T2 based methods, T2’ based methods do not need an ex-vivo calibration 
curve and can be directly translated to oxygen saturation values. Also, T2’ based methods 
can quantify oxygen saturation at the tissue level as T2’ tends to be more sensitive to 
signal alterations induced by paramagnetic deoxyhemoglobin. However, T2’ based 
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methods are more susceptible to background field inhomogeneities arising from air-tissue 
interfaces, such as those due to frontal nasal sinuses. Additionally, several assumptions 
are made in the analytical signal model. First, it is assumed that the blood vessels form a 
random network of cylinders so that a statistical approach can be used to approximate the 
signal equation. This assumption might not hold for voxels containing a dominant blood 
vessel, such as a pial vein or dural venous sinuses. Second, the signal model incorporates 
alterations in extravascular signal alone ignoring intravascular contributions. Since in a 
normal healthy brain the cerebral blood volume is small (2-5%), the signal contributions 
originating from the intravascular space can be assumed to be negligible. However in 
certain pathological situations such as high grade tumors, arterio-venous malformations 
etc. this assumption might not be valid. Appropriate modifications to include 
intravascular signal contributions will be necessary in such cases. Finally, the signal 
model assumes a static dephasing regime and does not account for signal loss caused by 
diffusion. Diffusion effects depend on pulse sequence, echo time, vessel size etc. and 
cannot be always ignored [61-62]. For example, for small diameter vessels (<25m) 
diffusion effects can be substantial [63].      
 
1.3 Outline of Thesis Chapters 
In this dissertation we introduce an approach for simultaneous rapid measurement 
of total cerebral blood flow and global SvO2 to derive global CMRO2. In Chapter 2 we 
explore the feasibility of using the proposed methodology for in-vivo CMRO2 
quantification and test the validity of underlying model assumptions for in-vivo 
applications. In Chapter 3 the accuracy of the proposed MR susceptometry based 
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oximetry is evaluated against the clinically established gold standard (co-oximetry 
measurements). The sensitivity of the method to detect physiologically expected changes 
in response to a stimulus (hypercapnia) is then evaluated in Chapter 4. The following 
chapters explore the clinical translation of the method to study neonates with congenital 
heart disease (Chapter 5) and adolescents with sickle cell disease (Chapter 6) in small 
pilot studies. Both populations are at risk for cerebral ischemia, and quantifying cerebral 
hemodynamic and metabolic parameters would conceivably provide insights into the 
disease pathophysiology and have implications in the clinical management of these 
patients. Lastly, in Chapter 7 we propose a fast T2 based method for determining oxygen 
saturation of blood. The method relies on complex difference subtraction of velocity 
encoded projections which unlike susceptometry based oximetry is not restricted by the 
vessel orientation with respect to main magnetic field or the need for surrounding 
reference tissue.  
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Chapter 2: MRI Estimation of Global Brain Oxygen Consumption Rate 
 
2.1 Abstract 
Measuring global cerebral metabolic rate of oxygen (CMRO2) is a valuable tool for 
assessing brain vitality and function. Measurement of blood oxygen saturation (HbO2) 
and flow in the major cerebral outflow and inflow vessels can provide a global estimate 
of CMRO2. We demonstrate a rapid noninvasive method for quantifying CMRO2 by 
simultaneously measuring venous oxygen saturation in the superior sagittal sinus with 
MR susceptometry-based oximetry, a technique that exploits the intrinsic susceptibility of 
deoxygenated hemoglobin, and average blood inflow rate measured with phase-contrast 
(PC)-MRI. The average venous HbO2, cerebral blood flow and global CMRO2 values in 
eight healthy, normal study subjects were 64  4 %, 45.2  3.2 mL/100g/min and 127  7 
mol/100g/min, respectively. These values are in good agreement with those reported in 
literature. The technique described is noninvasive, robust and reproducible for in vivo 
applications, making it ideal for use in clinical settings for assessing pathologies 
associated with dysregulation of cerebral metabolism. Additionally, the short acquisition 
time (~30s) makes the technique suitable for studying the temporal variations in CMRO2 
in response to physiological challenges.  
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2.2 Introduction 
Under normal physiologic conditions, aerobic metabolism of glucose is the 
primary metabolic fuel for energy production in the human brain [64-65]. Although the 
brain represents only 2% of body weight, it receives 15% of the cardiac output and 
consumes 20% of the total body oxygen [66-67]. The above highlights the critical 
dependence of brain function on continuous, efficient utilization of oxygen and the 
organ’s heightened vulnerability and sensitivity to alterations in oxygen supply. There is 
a considerable body of research exploring the dysregulation of glucose oxidative 
metabolism in diseases of the brain. Many of the most common disorders of the brain 
such as Alzheimer’s, Parkinson’s , Huntington’s, Multiple System Disorder, Progressive 
Supranuclear Palsy, Mitochondrial Encephalomyopathy, and others, have been found to 
be associated with alterations in cerebral oxygen metabolism [68-72]. Additionally, a 
measure for assessing cerebral metabolic rate of oxygen consumption (CMRO2) will 
further enhance our understanding of normal cerebral physiology during rest, sleep, 
anesthesia, aging, functional brain tasks and physiological challenges as well as be useful 
for evaluating the effect of systemic disease processes such as hypertension and diabetes 
on cerebral oxygen metabolism. Thus, a robust and reliable measure for quantifying 
CMRO2 would serve as an important tool for exploring the neuro-metabolic-
hemodynamic relationships during cerebral activation and pathophysiological conditions. 
Currently, CMRO2 is not routinely measured clinically, in that several practical 
limitations have prevented its widespread application. Positron emission tomography 
(PET) provides the most direct measurement of CMRO2 via imaging of the accumulated 
inhaled 15O labeled radiotracers in the brain, which, following distribution into the tissue, 
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are converted into 15O-labeled water [37, 73]. PET is, however, restrictive in terms of its 
utility due to the high radiation dose, relatively complex setup required for the constant 
delivery of radio-labeled gases, high associated expenses and long scan times, during 
which it is assumed that no change in physiological state occurs.  
Other methods for quantifying CMRO2 have relied on estimating venous oxygen 
saturation levels using jugular vein oximetry involving catheterization and measuring 
flow via optical measurements or Doppler ultrasound [74]. However, due to the 
invasiveness of the technique, it is prone to complications such as carotid artery puncture 
(incidence 1-4.5%), hematoma formation, jugular vein occlusion, thrombosis, risk of 
bacteremia and other infections [19]. Additionally, the accuracy of the method is highly 
dependent on personnel skill and experience.  
In a recent paper, an MRI approach for quantifying CMRO2, based on the 
measurement of transverse relaxation time T2 [46], has been described [56]. The method, 
termed T2-relaxation-under-spin-tagging (TRUST)[53], allows non-invasive estimates of 
venous oxygen saturation in vivo. However, T2-based methods rely on an in vitro 
calibration curve to translate T2 measurements to venous oxygen saturation levels [46]. 
Additionally, an acquisition time of over 4 minutes limits the utility of this technique for 
obtaining time-resolved CMRO2 measurements as would be desirable to study the effect 
of physiological challenges and functional tasks on the global rate of oxygen 
consumption. 
In this study we present a rapid non-invasive method for quantifying CMRO2. The 
method comprises of simultaneous estimation of oxygen saturation and cerebral blood 
flow in the major vessels draining and feeding the brain.  Specifically, venous blood 
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oxygen saturation is estimated using MR susceptometry-based oximetry [41, 75] that 
quantifies the intravascular bulk magnetic susceptibility relative to surrounding tissue by 
exploiting the inherent paramagnetism of deoxyhemoglobin in erythrocytes. The blood 
flow is quantified in the major inflow vessels (internal carotid arteries and vertebral 
arteries) using phase-contrast MRI [76-77].  
 
2.3 Materials and Methods 
2.3.1 Estimation of Cerebral Metabolic Rate of Oxygen Consumption (CMRO2)  
As previously discussed in Chapter 1, CMRO2 can be estimated by combining 
venous and arterial oxygen saturation and cerebral blood flow measurements using Fick’s 
principle [13], 
                   222 OSOSCBFCCMRO vaa      [2.1] 
where CMRO2 is the cerebral metabolic rate of oxygen consumption in mol/min/100g, 
CBF is the total cerebral blood inflow to the brain in mL/100g/min, SaO2 and SvO2 
represent the arterial and venous oxygen saturation levels, respectively, Ca is the oxygen 
concentration in moles of O2 per 100mL of blood. Based on a typical hemoglobin level of 
14.7g/dL (at a hematocrit of 0.42) and an O2 carrying capacity of  1.39mL of O2/ g of 
haemoglobin [78], using the ideal gas law Ca was calculated to be 836 mol O2/100 mL 
blood. For our CMRO2 measurements, an arterial oxygen saturation value of 98% was 
assumed. This is a valid assumption for normal healthy adults under resting conditions 
where arterial blood is almost fully oxygenated [78]. SvO2 was estimated by MR blood 
oximetry. We note that, in principle, MR oximetry can be used to estimate SaO2 as well. 
However, this measurement of cerebral arterial supply is challenging as the presence of the 
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oropharynx or trachea in the neck causes severe susceptibility induced magnetic field 
perturbations, making the SaO2 measurement in the internal carotid and vertebral arteries 
difficult. The measurement in the distal cerebral arterial vasculature (such as the middle 
cerebral artery) is hampered by constraints such as vessel tortuosity, orientation with 
respect to Bo field and small vessel diameter (~2mm).The flow rate was quantified with a 
non-gated phase contrast MRI technique [76-77] (see below). 
 
2.3.2 MR Oximetry and Flow Quantification 
MR-susceptometry based oximetry [41, 75] relies on the magnetic susceptibility 
difference between intravascular blood (due to paramagnetic deoxyhemoglobin) and 
surrounding tissue to quantify intravascular oxygen saturation. Additional details on 
measurement theory can be found in chapter 1.  
The flow rate was quantified with a phase contrast technique [76-77]. In the 
implementation used the imaging pulse sequence is played out twice in an interleaved 
fashion. In both acquisitions the zeroth gradient moment for the slice-selection gradient 
(i.e. the gradient parallel to the direction of flow) is zero, as usual, thus the signal from 
stationary tissue protons is nulled upon subtraction of the two datasets. The first gradient 
moment (  tdttGM )(1 ) of the two interleaves that determines the sensitivity of the 
measured phase difference,  , accrued by the flowing spins, is given as: 
                                                          vM 1                                   [2.2]   
where 1M  is the difference in first moment between the two interleaves. It is convenient 
to introduce the parameter VENC [79], which is the velocity causing a phase shift of  
radians. In this manner Eq. (5) can be rewritten as: 
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         VENCv /     [2.3] 
from which the blood flow velocity is determined pixel by pixel.  It should be noted that the 
maximum velocity measured should not exceed the user defined parameter VENC in order 
to avoid phase aliasing. 
 
2.3.3 MR Protocol 
MR experiments were performed on a 3T Siemens TIM Trio system using vendor 
supplied head and neck coils. An interleaved 2D gradient-recalled echo (GRE) sequence 
programmed in SequenceTreeTM [80-81], shown in Figure 2.1, was used to obtain 
simultaneous oxygen saturation and cerebral blood flow measurements. The sequence 
consisted of four interleaves (Figure 2.1). All but the fourth interleave (VENC=60 cm/s) 
were flow compensated (i.e. the slice-selection gradient structure was chosen so that 
M1=0) and the interleaves alternated between making the acquisition at the level of the 
superior sagittal sinus (SSS) and mouth orifice to measure oxygen saturation and total 
cerebral inflow, respectively.  The first and the third interleaves with an echo time (TE) 
of 7.025 and (7.025 + 2.5) ms (inter-echo time, TE = 2.5ms), respectively, were 
acquired at the level of SSS in the occipital region for blood oxygenation quantification.  
This interleaved acquisition scheme allowed us to attain short inter-echo times thereby 
avoiding phase wrapping. The second and fourth interleaves were acquired with the same 
echo time (7.025ms) at the level of mouth orifice and were used to quantify average 
velocity. For the static phantom experiments, all interleaves were acquired at the same 
axial location and the data from the first and third interleaves was used for estimation of 
susceptibility relative to distilled water. 
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The scan parameters used were as follows: FOV = 208  208  5 mm3, voxel size 
= 1  1  5 mm3, dwell time = 15 s, flip angle = 25°, VENC = 60cm/s, repetition time 
(TR) = 30ms, yielding a total scan time of 28s. Additionally, a high-resolution scan at 
the level of mouth orifice over the same slice as chosen above, voxel size = 0.5  0.5  5                         
mm3, FOV = 208  208  5 mm3, was obtained to improve accuracy of the estimation of 
the vessel cross sectional area. 
The location of the SSS was prescribed based on a sagittal image (Figure 2.4a). A 
multi-slice axial localizer was used to choose a slice with a relatively straight section of 
Figure 2.1: Interleaved 2D-GRE sequence alternating between two anatomic locations 
(Gx = frequency-encoding gradient, Gy = phase-encoding gradient, Gz = slice-
selection gradient). All but the fourth interleave are flow compensated along the slice-
select direction. The fourth interleave is flow encoded with VENC = 60cm/s. The echo 
time difference (TE) between the first and third interleaves is 2.5ms (TE = 7.025ms). 
The dashed boxes represent sequence parameters that changed between the interleaves.  
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SSS based on the observation of a relatively constant spatial position and cross-section of 
the vessel. The imaging slice was oriented axially, intersecting the SSS at about 1-2 cm 
above the confluence of sinuses (location at which the inferior sagittal, straight and 
transverse sinuses join the SSS). For the prescription of an appropriate slice for flow 
imaging, it is noted that the anatomic course of the internal carotid and vertebral arteries 
prior to 2nd cervical vertebra are both nearly parallel to the scanner’s z-axis. This parallel 
linear segment is variable in length due to individual differences in the location of the 
common carotid bifurcation, but is generally a few centimeters in length.  A multi-slice 
axial localizer was used to identify this segment in the region of the oropharynx, based on 
the observation of a relatively constant in-plane position and cross-section of the vessel, 
as it is at the same axial location as the 2nd and 3rd cervical vertebrae.   
Additionally, we acquired a T1-weighted 3D magnetization-prepared rapid 
gradient-echo (MPRAGE) [82] image dataset (voxel size = 1 x 1 x 1 mm3) to estimate the 
intracranial volume in each subject, so that the CMRO2 levels could be calculated per 
100g of brain mass. An average brain density of 1.05g/mL was used for the above 
calculation [83]. 
The time taken for various scans were: multi-slice localizer (1:12 mins), 2D-GRE 
for simultaneous oxygen saturation and flow measurements (28 s), T1-MPRAGE (1:37 
mins), total scan duration for global CMRO2 estimation (3:17 mins). 
 
2.3.4 Rationale for CMRO2 Measurement Locations 
The SSS was preferred over the internal jugular vein (IJV, another major draining 
vein) in light of the often severe susceptibility artifacts caused by the proximity of air 
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spaces such as the oral cavity and trachea. Additionally, previous work by Xu et al. [56] 
as well as our work (elaborated in chapter 7) has revealed that the oxygen saturation 
levels in the SSS are comparable to those in the IJV. Phase measurement in the SSS is 
convenient and robust in the absence of major tissue interfaces with markedly different 
susceptibilities.  
Blood flow rates were measured at the neck level in the four feeding vessels, the 
left and right internal carotid and vertebral arteries. These vessels run parallel to the neck 
and the spine, respectively, and the chosen axial slice was perpendicular to the vessels 
and B0. Total cerebral blood flow was quantified by measuring inflow instead of outflow, 
as besides the IJV , certain secondary vessels such as the vertebral venous plexi also drain 
the brain [84]; flow measurements in these vessels is challenging. 
 
2.3.5 Phantom Experiments 
The blood vessel of interest (SSS) was modeled as a long circular cylinder (refer to 
chapter 1 for additional details) [41, 75]. The SSS runs in the sagittal groove from anterior 
to posterior head, tucked between the two cerebral cortices. As a result, the vessel has a 
triangular (rather than a circular) cross-section. In order to ensure the applicability of the 
previously validated model, a phantom was constructed. It consisted of two 12cm long 
tubes, with a circular and triangular cross-section, filled with paramagnetic gadolinium-
doped distilled water. The tubes were immersed in the center of a cylindrical plastic 
container filled with distilled water with the tubes oriented parallel to the container’s long 
axis. The concentration of Gd-DTPA in the solutions was 1, 1.25, 1.5 and 1.75mM so as to 
cover a range of relative magnetic susceptibilities matching the expected range of 
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susceptibility differences found between partially deoxygenated blood and tissue. The 
concentrations chosen corresponded to oxygen saturation values between 58-76% 
(assuming a Hct of 0.42). 
 
2.3.6 In-vivo Estimation of CMRO2 
The human subject studies were approved by the Institutional Review Board 
(IRB) of University of Pennsylvania and informed written consent was obtained from 
each volunteer. Eight healthy male volunteers participated in the study (mean age 25 
years; SD 5 years). The CMRO2 measurement was repeated three times in each volunteer 
at intervals of 5-10 minutes. In each session, three consecutive measurements were 
obtained to estimate the mean and standard deviation of each parameter for each session. 
The subject was asked to rise from the scanner table between each of the three scanning 
sessions. A cushioned head stabilizer was used to minimize motion and the subject was 
instructed to stay alert during the course of the scans as CMRO2 measurements are known 
be affected by degree of mental alertness. 
 
2.3.7 Data Analysis 
For HbO2 quantification phase maps were obtained, computed as the phase 
difference between echoes via: 
      *12arg ZZ   [2.4]  
where Z1 and Z2 represent complex values of a particular pixel in the images of two 
echoes, respectively; the asterisk denotes complex conjugate. The susceptibility 
difference between air and tissue compartments causes field inhomogeneity resulting in 
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low spatial-frequency modulation of the phase signal. To reduce its effect, a retrospective 
correction method was implemented which approximates the field inhomogeneity with a 
second-order polynomial, after appropriate masking and weighting the phase image with 
the corresponding masked magnitude image [85]. In order to estimate the susceptibility 
values, the average phase difference between the region of interest and the neighboring area 
(adjacent water in the phantom experiments and tissue for in vivo studies) was calculated. It 
should be noted that at the investigated field strength, the phase difference images acquired 
at relatively short TE’s are not sensitive to the white and gray matter boundaries [86] as 
shown in Figure 2.4d. The background brain parenchyma was also used as reference tissue 
in a study utilizing a similar method for quantifying oxygen saturation in pial veins [41]. 
For the quantification of total cerebral blood flow, a signal intensity threshold was 
applied to the high-resolution magnitude image to obtain a mask for each of the four 
vessels of interest (internal carotid and vertebral arteries) for measuring cross-sectional 
area. The mask was then downscaled to match the resolution of the phase-contrast image 
and applied to the velocity maps to obtain whole-brain cerebral blood velocity in 
mL/min. Total brain volume was estimated using a semi-automated region growing 
algorithm in ITKSnap [87]. Analysis of Variance (ANOVA) was used to test inter-subject 
variability of various test parameters. Within subject coefficient of variation (CV) and 
intra-class correlation coefficient (ICC) were used to test technique reproducibility. 
Additionally, the correlation between the arterio-venous oxygen saturation difference 
(AVO2D = SaO2 – SvO2), and global CBF was investigated. The above were performed 
using JMP Statistical Software Package 7.0 (SAS, Cary, NC). 
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2.4 Results 
2.4.1 Phantom Experiments 
Figure 2.2 shows the phase difference images of the four phantom experiments. 
The relative mean difference between the susceptibility values derived from the phase 
measurements in the circular and triangular cross section phantoms was 2.6% which 
would correspond to an average absolute difference in oxygen saturation of 0.8% at a Hct 
of 0.42 (Table 2.1).  
 
2.4.2 In-vivo Experiments 
Magnitude and velocity images for the estimation of the whole-brain cerebral blood flow 
are displayed in Figure 2.3. Figure 2.4 shows the magnitude and phase difference 
Figure 2.2: Phase difference 
images of the cross-sectional 
area of the circular and 
triangular phantoms containing 
(a) 1mM, (b) 1.25mM, (c) 1.5mM 
and (d) 1.75mM Gd-DTPA in 
distilled water. 
Table 2.1: The difference in 
oxygen saturation between the 
circular and triangular phantom 
tubes for various concentrations of 
Gd (assuming Hct = 0.42). 
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images acquired at the level of the SSS used for the estimation of oxygen saturation. The 
average values of venous oxygen saturation and cerebral blood flow for the group of 
eight subjects were 64  4 % and 45.2  3.2 mL/100g/min, respectively. Mean CMRO2 
values found were 127  7 mol/100g/min. The results of the reproducibility test 
performed in 8 subjects are summarized in Table 2.2.  The oxygen saturation and flow 
measurements in the three sessions varied maximally by 2% HbO2 and 2.3 mL/100g/min, 
respectively. The maximal variation in CMRO2 over the three sessions for the group was 
8 mol/100g/min.Figure 2.5a shows a scatter plot of the mean CMRO2 values computed 
for each subject for the three scanning sessions. The coefficients of variation for CMRO2, 
venous oxygen saturation and CBF measurements were 3.2 %, 2.3% and 3.1%, and the 
intra-class coefficients (ICC) were 0.94, 0.98 and 0.97, respectively. The AVO2D was 
found to be negatively correlated with global CBF across the subjects (R2 = 0.74, 
p<0.006), with large AVO2D corresponding to low global CBF values (Figure 2.5b). 
 
 
 
 
 
 
 
 
 
Figure 2.3: (a) Axial magnitude image 
of mouth orifice highlighting the major 
inflow vessels (internal carotid and 
vertebral arteries; red arrows); (b) 
corresponding velocity map used for the 
calculation of total cerebral blood flow 
rate. 
(a) (b) 
  
 
35
2.5 Discussion and Conclusions 
We have introduced an MRI-based technique for quantifying absolute CMRO2 in 
humans in vivo. The method is robust, reproducible and allows for simultaneous 
measurement of oxygen saturation and flow rate. 
 
 
 
 
 
 
 
 
 
 
 
 
Our protocol takes around 3 mins for whole-brain CMRO2 quantification (including 
localizers), where the physiologically relevant SvO2 and blood flow estimation takes less 
than 30s. The short acquisition times afforded by technique make it suitable for 
monitoring changes in CMRO2 in response to physiological challenges. The measured 
Figure 2.4 (a) Sagittal (b) Coronal and (c) Axial magnitude images of the brain 
highlighting superior sagittal sinus (red arrow). Notice that the sinus is fairly straight; the 
highlighted red line represents the imaging slice location. Zoomed in axial (d) magnitude 
and (e) phase image of the superior sagittal sinus. 
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whole-brain CMRO2 level averaged across the eight study subjects was 127  7 
mol/100g/min, which is in good agreement with the values reported in literature [56, 88-
89]. Our results illustrate that the technique can estimate CMRO2 with a high degree of 
precision and reliability (average CV and ICC of 3.2% and 0.94, respectively). 
 
 
 
 
 
 
This level of precision is comparable to that reported using more invasive 
techniques. The strong correlation observed between the AVO2D and global CBF is 
expected and has been reported previously [56](Figure 2.5b). The inter-subject variations 
in venous oxygen saturation, cerebral blood flow and CMRO2 measurements were found 
to be statistically significant as compared to the intra-subject variations in these 
parameters (two-tailed analysis of variance, p<0.003). These inter-subject differences 
observed are physiologic and represent normal differences between subjects and the 
range seen is consistent with literature reports evaluating oxygen saturation and CMRO2 
levels using invasive methods such as jugular vein catheterization and PET [88, 90-92]. 
 
Table 2.2:  Estimated total cerebral blood flow (CBF), venous oxygen saturation in SSS 
(SvO2), and CMRO2 levels in eight subjects evaluated in three successive sessions to 
demonstrate short-term reproducibility. Global averages are given in the last row.   
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Other MRI based approaches for the noninvasive quantification of blood 
oxygenation have resorted to measurements of the transverse relaxation times, T2 and  
T2*, which are also related to deoxyhemoglobin concentration in erythrocytes as detailed 
in chapter 1 [46, 93-94]. Unlike susceptometry-based oximetry, the sensitivity of T2 and 
T2* based measurements varies with the level of hemoglobin oxygen saturation (both 
depend quadratically on HbO2; though the relationship is piece-wise linear over a small 
range of HbO2 values) [46, 93-94]. The in vivo estimation of these parameters in the 
major blood vessels is complicated by body motion (requiring suspended respiration), 
pulsatile blood flow, (necessitating cardiac gating), and the need for long pulse repetition 
times, leading to prolonged acquisition times [93, 95]. The above factors make these 
methods less suited for measuring physiological variations in CMRO2 over experimental 
time frames as well as for clinical evaluations. Alternative approaches utilizing PET or 
Figure 2.5: (a) Scatter plot of CMRO2 for each subject over three scanning sessions illustrating 
reproducibility The vertical span of each diamond represents the 95% confidence interval (CI) for 
each group.  (b) Correlation between AVO2D and total CBF in the eight subjects (R2  = 0.74, 
p<0.05). Note that subjects with higher CBF values tend to have lower AVO2D.  
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SPECT [37, 96], rely on contrast agents, are invasive (generally requiring arterial/venous 
lines for the administration of contrast agents), lengthy and expensive. 
Due to the thin medial layer and lower distending pressure in veins, the SSS does 
not have a circular (or elliptic) cross-section as shown in Figure 2.4c. However, since || 
<<1 the induced field inside the vessel is parallel to the applied field [97], and more 
importantly, the effect of cross-sectional geometry is negligible as long as the vessel is 
parallel to the applied field. In our study, the SSS, used for SvO2 measurement, was 
essentially parallel to Bo (average tilt angle across subjects < 6) and has negligible 
curvature at the measurement site (Figures 2.4a, b). The above predictions are supported 
by our phantom experiments (Figure 2.2, Table 2.1), consisting of test tubes with 
triangular and circular cross section filled with varying Gd-DTPA doped water 
concentrations positioned parallel to Bo. The uniform phase accumulation inside the 
triangular tubes, the clear phase separation from the surrounding distilled water and 
strong agreement with the susceptibility measurement in the circular tubes lends strong 
support to the validity of the model adopted in the present work. The largest relative 
difference in measured susceptibility between tubes of circular and triangular cross-
section was less than 5%, which translates to a difference of less than 2% HbO2. In 
keeping with the requirements for applicability of the model, the SSS also complies with 
the long cylinder approximation as discussed previously in chapter 1. Posteriorly, the 
typical sagittal sinus segment has length to diameter ratios of >6 (typical vessel diameter 
~ 5-6 mm; vessel segment length ~ 4cm; Figures 2.4a, b). 
 Lastly, a few constants prone to inter-subject variability and used in the 
estimation of CMRO2 can be additional sources of error. A typical hematocrit value of 
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42% was used for all our measurements. We expect that the variation in hematorcit 
within our study cohort to be minimal (all males, age: 25  5 years) and could be 
obtained by blood draws. A typical SaO2 value of 98% was used for all the calculations. 
Though this value is widely accepted in literature, an accurate measurement of SaO2 can 
easily be obtained at a different site where an artery is present.  
The present technique estimates global CMRO2 but not regional. All previously 
explored methods for regional CMRO2 quantification are model based and are still in their 
developmental stages. One such approach relies on the estimation of the contribution to 
the effective transverse relaxation rate from regional magnetic field inhomogeneity (T2’) 
resulting from partially desaturated blood in the capillary bed. From this quantity, along 
with a measurement of capillary volume, the oxygen extraction fraction is derived [59, 
98]. Additional details on this method can be found in chapter 1. Nonetheless, the 
importance of a global measure to estimate absolute cerebral metabolism is of interest in 
its own right. 
In conclusion, we have demonstrated a noninvasive MRI-based approach for the 
estimation of global whole-brain CMRO2 based on simultaneous measurement of average 
blood flow rate and oxygen saturation in major inflow and outflow vessels to the brain. 
The noninvasive nature of the technique, its robustness and straightforward 
implementation make it suitable for applications in clinical settings for the assessment of 
pathologies associated with disorders of brain metabolism. Rapid acquisition afforded by 
the technique makes it specially suited for studying temporal variations in CMRO2 under 
physiological challenges such as hypercapnia, hyperoxia, caffeine stimulation and 
sedation, as well as under functional brain paradigms.  
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Chapter 3: Investigating the Magnetic Susceptibility Properties of Fresh 
Human Blood for Noninvasive Oxygen Saturation Quantification 
 
3.1 Abstract 
Quantification of blood oxygen saturation on the basis of a measurement of its magnetic 
susceptibility demands knowledge of the difference in volume susceptibility between 
fully oxygenated and fully deoxygenated blood (do). However, two very different 
values of do are currently in use.  In this work we measured do as well as the 
susceptibility of oxygenated blood relative to water, oxy, by MR Susceptometry in 
samples of freshly drawn human blood oxygenated to various levels, from 6 to 98% as 
determined by blood gas analysis. Regression analysis yielded 0.273 ± 0.006 and - 0.008 
± 0.003 ppm (cgs) respectively, for do and oxy, in excellent agreement with previous 
work by Spees et al (MRM 2001; 45:533-542).  
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3.2 Introduction 
Hemoglobin is derived from the words ‘heme’ meaning iron and ‘globin’ 
referring to its globular shape. The heme iron transitions from a low-spin state in 
oxyhemoglobin to a high-spin state in deoxyhemoglobin accounting for the former being 
diamagnetic and the latter paramagnetic. This oxidation state dependence of 
hemoglobin’s magnetic properties is the basis of contrast for various MRI methods such 
as blood oxygenation level dependent (BOLD) MRI [99] , susceptibility weighted 
imaging (SWI) [100], detection of acute hemorrhage [101], etc. While the above methods 
exploit qualitative differences in bulk magnetic susceptibility between oxy and deoxy- 
hemoglobin, their quantification enables determination of intravascular oxygen 
saturation.  
In recent years several articles have appeared in which venous oxygen saturation 
was quantified by magnetic resonance techniques [41, 44, 46, 53, 100, 102]. These 
approaches can be  broadly classified as T2 [46, 53] and T2’ [102] based intravascular and 
extravascular methods, and susceptibility-based phase methods [41, 103]. The former 
rely on an empirical relationship to derive oxygen saturation from relaxation rates while 
the latter are essentially calibration-free. Both methods have been discussed in detail in 
chapter 1. Briefly, phase methods are based on an exact solution of Laplace’s equation 
for the scalar magnetic potential, yielding a simple equation of the fractional induced 
field inside, relative to the field outside the vessel. The induced field can be translated to 
oxygen saturation values by approximating the vessel as a long cylinder combined with 
the knowledge of the volume susceptibility difference between fully oxygenated and 
deoxygenated blood (do) and hematocrit (Hct). Several groups have applied the method 
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for various in vivo applications [42, 44, 104-105]. However, much of the prior work has 
relied on two very different values of do, 0.18 ppm [106] and 0.27 ppm [107] (CGS 
units), yielding substantially different oxygen saturations. Although several prior studies 
have evaluated this constant in various ways, no consensus appears to exist on its actual 
value [106-109]. 
Phase based oxygen saturation measurements have recently been used to evaluate 
global (chapter 2) and regional cerebral oxygen extraction fractions (OEF) and cerebral 
metabolic rate of oxygen consumption (CMRO2) at rest as well as during metabolic 
(chapter 4) and motor tasks [104-105, 110-111]. The soundness and reliability of the 
results of these experiments is incumbent on the accuracy of the derived venous oxygen 
saturation. Thus, knowledge of the correct value of do is of paramount importance. 
In this chapter we aimed to measure do  using a framework similar to that 
utilized by Weisskoff et al [106]. The experiments were planned to simulate in vivo 
conditions and to overcome some of the limitations of previous studies. The methodology 
used in the present work has previously been shown to yield accurate and reliable 
susceptibility values[85]. Additionally, we examined potential sources of error in oxygen 
saturation derived by MR susceptometry and compared these to values obtained by blood 
gas analysis, widely regarded as the clinical gold standard. 
 
3.3 Methods 
3.3.1 Blood Preparation 
Fresh whole-blood was collected from the antecubital vein of seven healthy 
human volunteers via venipuncture under an Institutional Review Board (IRB) approved 
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protocol. The samples were drawn in 7mL K2EDTA (1.7mg per mL of blood) Vacutainer 
tubes (Becton, Dickinson and Company, NJ, USA). Following collection the blood was 
stored over ice and immediately transferred to the hematology lab for preparation. All 
blood specimens were used within 6 hours after collection.  
The samples were pipetted into 2mL large-surface-area cylindrical tubes 
(diameter = 20mm, height = 6mm) to ensure maximal exposure to the diffusing gases and 
placed into an Eppendorf Thermomixer (New Brunswick, NJ, USA) via a custom-
designed mount. This mount had an air-tight seal with inlet/outlet nozzles for adding 
gases. Subsequently, the blood was oxygenated to varying levels (range: 6-98 %) by 
either exposure to room air or a continuous stream of N2 gas, while being maintained at 
37C. To prevent the RBCs from settling or foaming and to ensure maximal surface area 
for gas diffusion, the samples were continuously agitated. The samples had variable 
incubation periods to achieve their desired level of oxygenation (verified by blood gas 
analysis). 
Blood samples from multiple large surface-area 2mL tubes were transferred into 
6mL glass cylindrical tubes (diameter: 10 mm; height: 75mm) and sealed with a rubber 
stopper in preparation for MR scanning. Subsequently, the blood was injected into the 
MR sample tube via an inflow needle and another needle was placed for air outflow. The 
above procedure ensured that the tubes were filled completely with no remaining air 
spaces. The sample tubes were gently tumbled to prevent the blood from settling and 
maintained at a temperature of 37C. 
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Four to five air-tight blood samples of different oxygenation were prepared per 
subject in the above manner (total of 30 samples with variable oxygenation levels for the 
entire study). The samples for each subject were placed in a cylindrical container filled 
with distilled water at 37C and brought to the MR suite for scanning. The setup in MR 
scanner included a heating pad to ensure a constant temperature of 37C throughout the 
experiment. Care was taken to scan the samples quickly (less than 1.5min after they were 
placed in the scanner) to prevent red blood cell (RBC) settling. Prior work had shown that 
settling of RBCs can substantially affect the NMR line shape; with settling occurring 
within 2-3 minutes [107]. After MRI, oxygen saturation level and hematocrit in each tube 
were re-measured in the hematology lab using the Radiometer Blood Gas Analyzer 
(Model: ABL 725, Radiometer Medical ApS, and Denmark). To examine the precision of 
the phase-based MRI method, samples from the last three subjects were scanned five 
times each. Between measurements, the sample tube assembly was removed from the 
scanner and gently tumbled to prevent RBC settling.  
 
3.3.2 MR Protocol   
All MRI measurements were performed on a 3T Siemens Tim Trio system 
(Siemens Medical Solutions, Erlangen, Germany) using a 12-channel head coil. The 
cylindrical container was placed in the scanner with its long axis parallel to the B0 field. 
A 2D gradient-recalled Echo (GRE) sequence was used to obtain axial phase maps with 
the following imaging parameters, voxel size: (voxel size =1x1x5 mm3, FOV = 76mm x 
76 mm, flip angle = 25, TE = 7.2ms, TR = 70ms, number of echoes = 2, echo spacing 
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(TE)= 2.5ms, total scan time ~11s). Phase difference ( was computed by taking the 
difference of the phase images from the two echoes.  
The susceptibility differences between various compartments (such as air, tissue 
etc.) cause field inhomogeneities and result in low spatial-frequency modulations of the 
phase signal. To minimize this interfering effect a retrospective correction method was 
implemented, which approximates the field inhomogeneity by a second-order 
polynomial. The compartments where oxygen saturation was to be determined were 
masked out and the phase difference image was weighted with the corresponding masked 
magnitude image. The robustness and accuracy of the method for quantifying 
susceptibility has been previously validated by some of the present authors [85]. The 
experimental set-up, duplicated in the current work, consisted of an array of sample tubes 
filled with Gd-doped water of various concentrations and known volume susceptibilities. 
The susceptibility difference () between blood and water was computed from 
the phase difference () between an ROI placed inside the cross sectional area of each 
tube and the surrounding water as 
TEB 

0
3

                                               [3.1] 
do was obtained from the slope of /Hct, where Hct are the individual hematocrit 
levels, and the concentration of deoxy-Hb (1-HbO2) obtained from blood gas analysis (Eq 
3.2):  
        [3.2] 
where oxy is the susceptibility difference between fully oxygenated blood and water. In 
this model it is assumed that the plasma~ water [107].  
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3.3.3 Statistical Analysis 
Regression lines were calculated using standard linear regression.  Bland-Altman 
method was used to evaluate agreement between blood gas and phase based oxygen 
saturation measurements. The Bland-Altman test is a statistical method to compare two 
different methods of measurement and test if one can be replaced by another. The mean 
difference between the two methods for measuring oxygen saturation (‘bias’) and 95% 
limits of agreement (1.96 x Standard deviation) are then calculated. In order to be 
equivalent, 95% limits must include 95% of differences between the two measurement 
methods [112]. All analyses were performed using JMP (Version 7, SAS Institute  Inc., 
Cary, NC ).  
 
 
 
 
3.4 Results 
Representative phase difference maps for calculating blood susceptibility are 
shown in Figure 3.1. The slope of the regression line of /Hct versus deoxygenation 
yielded a value of 0.273 ± 0.006 ppm (CGS units) for do and a y-intercept of  - 0.008 ± 
0.003 ppm corresponding to oxy, the susceptibility of fully oxygenated blood relative to 
water (Figure 3.2). Hematocrit and deoxygenation (1-HbO2) ranges for the 
measurements were 36 to 49% and 2 to 94%, respectively. Repeated measurements of 
Figure 3.1:  Representative phase difference images at various HbO2 levels. Note the change 
in contrast at different oxygenation levels. 
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blood susceptibility at a given oxygen saturation and hematocrit level yielded a 
coefficient of variation of <5%. Figure 3.3 shows Bland-Altman plots for assessing the 
agreement between phase and blood gas analyzer derived oxygen saturation 
measurements. The mean bias and limits of agreement were -0.7% and ±6.4 % HbO2, 
respectively. A 95% confidence interval for the mean yielded a lower and upper limit of -
2.0 and 0.6% HbO2, respectively, suggesting that the two measurements are not 
significantly different from one another. Figure 3.4 illustrates the sensitivity of the 
derived oxygen saturation to hematocrit, do and . A fractional error of Hct,, do  
and    in Hct, do and phase (),  respectively, introduces an absolute error HbO2 , 
     22 1 HbOHbO                                                                                   [3.3] 
in the derived oxygen saturation estimates; where  
 
(see Appendix for derivation of equation 3.3). Thus, errors in the above parameters affect 
lower oxygen saturation values more severely. Additionally, for a given phase value the 
sensitivity of HbO2 measurements to uncertainties in Hct and do is greatest at low 
values of Hct and do as is evident from the increased slope of the surface plot in Figure 
3.4a at low values of these parameters. Figure 3.4b illustrates that phase errors lead to 
greater absolute errors in HbO2 at low Hct values.  
 
3.5 Discussion and Conclusions 
In this work we determined the bulk volume susceptibility difference between  
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fully oxygenated and deoxygenated human blood by varying blood oxygen saturation ex-
vivo in a controlled environment. The ability of the proposed phase difference method 
and processing technique to determine  with high precision and accuracy has been 
verified previously [44, 85]. Further, we evaluated the agreement of MR susceptometry 
derived oxygen saturation measurements with the clinical gold standard, blood gas 
measurements.  
 
 
 
 
 
 
Figure 3.2:  Susceptibility difference () between blood and surrounding distilled water 
normalized to individual hematocrit (Hct) level in each subject plotted against the level of 
deoxygenation. The slope of the regression line represents the susceptibility difference 
between fully oxygenated and deoxygenated blood (do) and intercept the susceptibility 
difference between fully oxygenated blood and water (oxy). 
Figure 3.3: Bland-Altman plots showing the 
agreement between MR susceptometry and 
Blood Gas Analyzer derived oxygen saturation 
values based on do = 0.27ppm and oxy = 
0.008 ppm. The red and green lines indicate the 
mean bias and the limits of agreement (1.96  
standard deviation), respectively. 
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The value of do obtained in the present study (0.273 ± 0.006 ppm) is in 
excellent agreement with the work of Spees et al based on both NMR and SQUID 
magnetometry [107]. They obtained do = 0.27 ppm using both methods. Additional 
support for this value comes from calculations based on Cerdonio’s model using the 
magnetic moment of deoxyhemoglobin as initially determined by Pauling et al [107-108]. 
Our measurement of do is also in good agreement with earlier magnetic cell 
capture experiments by Kondroskii et al who studied the cellular trajectories of single 
RBC’s in response to a known magnetic field, from which they deduced a do value of 
0.29ppm [113]. More recent and technologically improved experiments by Zborowski et 
al on RBC magnetophoretic motilities yielded a value of 0.26ppm for do [114]. 
However, our measured value of do differs significantly from Weisskoff et al’s 
[106] who examined the phase difference between whole blood oxygenated to various 
levels and distilled water. 
 
 
 
 
 
 
 
Figure 3.4: Surface plot of HbO2 as a function of (a) susceptibility difference between fully 
deoxygenated and fully oxygenated blood, do, and hematocrit, Hct for a phase value 
corresponding to 65% HbO2 for Hct=0.42 and do=0.27ppm (b) and Hct for do=0.27ppm. 
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Based on oxygen saturation determined by blood gas analysis, they obtained a do value 
of 0.18ppm. This value is of the same order as an early rough estimate by Thulborn et al 
[109]. 
Although our experimental methodology somewhat resembles that used by 
Weisskoff, who performed field mapping with an asymmetric spin-echo sequence using 
an echoplanar readout, there are notable issues with that study that could have caused 
systematic errors. First, they used expired human blood. Hemorheological and 
hematological parameters are known to alter significantly with storage age. For example, 
erythrocytes swell, deform, lyse, become rigid and form micro-aggregates [115]. 
Additionally, blood chemistry can change substantially, with pH and 2, 3-DPG levels 
dropping with longer durations ex-vivo [115-116]. These changes significantly alter 
hemoglobin’s oxygen binding affinity. Second, there was no mention of any precautions 
taken to prevent blood from settling, which is known to substantially affect the NMR line 
shape within 2-3 minutes [107]. Thus, the conditions in Weisskoff and Kiihne’s 
experiments do differ substantially from those of freshly drawn or in vivo blood. 
In addition to the value for do, the intercept of the graph in Figure 3.2 provides 
an estimate for the value oxy. The observed value for oxy corroborates that fully 
oxygenated blood is slightly more diamagnetic than water. This finding was first reported 
by Pauling et al [38]. However, experiments by Cerdonio et al in the late 1970s put this 
into question. Their measured magnetic moment for oxyhemoglobin suggested a possible 
paramagnetic contribution [117-118]. In line with our measurements, recent work by 
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Savicki et al and Spees et al [107, 119] has not provided evidence for such 
paramagnetism. 
Most prior studies in which whole-blood oxygen saturation via the long-cylinder 
approximation and phase difference method was measured have ignored the contribution 
of oxy in equation 3.2; assuming its effect to be negligible [41-42, 44, 120]. Our results 
indicate that neglecting this contribution can introduce a slight bias (on the order of 2-3% 
HbO2) towards overestimating the oxygen saturation values. The effects of ignoring the 
diamagnetic contribution from fully oxygenated blood can be significant in some 
hematologic disorders. A case in point is sickle-cell disease (SCD). Sakhnini et al [121], 
who examined the magnetic properties of hemoglobin in SCD patients, found that fully 
oxygenated HbS is more diamagnetic than normal hemoglobin.  
Our results indicate that the mean bias ± limits of agreement between MR 
susceptometry derived and blood gas analyzer measured HbO2 values were -0.7±6.4%. 
The data thus suggest that HbO2 can be quantified by MR Susceptometry with clinically 
acceptable levels of agreement. The model used to derive whole-blood oxygen saturation 
from susceptibility measurements relies on the accuracy of Hct, do and phase as errors 
in their values are propagated into the derived oxygen saturation values. As predicted by 
Equation 3.3 and illustrated in Figure 3.4, uncertainties in these parameters cause the 
greatest errors at low oxygen saturation values as the errors scale according to the level of 
deoxygenation (1-HbO2). Thus, a population based estimate of Hct might suffice when 
using MR Susceptometry to determine oxygen saturation in arterial vessels. However, an 
accurate measurement of Hct is critical when applying this method in vessels where low 
oxygen saturations are expected. In general, uncertainties in HbO2 estimates are 
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dominated by errors in Hct and do at low oxygen saturations and by low phase SNR at 
high oxygenation levels. 
It should be noted that our measured value do might not be applicable to all 
clinical scenarios. Our experimental do was calculated with normal adult hemoglobin. 
Caution must be exercised when using this constant for oxygen saturation determination 
in individuals with variable hemoglobin types (e.g. HbF, HbS etc.). There is some 
disagreement in literature on the possible contribution of steric heme-heme interactions 
on the net dipole moment of hemoglobin (calculated per heme). Traditionally myoglobin 
has been used to study such interactions as it consists of a single heme group conjugated 
to a globin chain. Thus it is representative of true magnetic moment of heme attached to 
globin in the absence of any heme-heme interactions. While early experiments on the 
magnetic moment of myoglobin found values similar to those obtained for hemoglobin 
(per heme) [122], later experiments contradicted this finding [123]. Such interactions, if 
present, could have implications on the magnetic moment of deoxyHb and hence do. It 
is conceivable that in the event of variations in globin chains (e.g. individuals with 
hemoglobinopathies), the aforementioned steric heme-heme interactions could be 
affected, amongst other variables, thereby altering do. 
In conclusion, our results strongly support a do value of 0.27 ppm for normal 
adult human blood. Deviations from the present value in prior work are likely due to 
experimental inadequacies. 
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3.6 Appendix 
From Equations 3.1 and 3.2, HbO2 can be calculated as, 
                      (A1) 
         
Constants other than Hct, do and Δ are user specified or empirical and can be replaced 
by constant k for simplicity, yielding. 
                          (A2) 
 
Using basic rules of error propagation, the absolute error (ε) in HbO2 can be estimated as 
                                                                        
(A3) 
 
Computing partial derivatives and substituting  
HctHctdHctd     , and dododod    
with σ representing the fractional error, yields 
 
           (A4) 
 
Rearranging and substituting Eq. A2, gives 
         (A5) 
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Chapter 4: Rapid Magnetic Resonance Measurement of Global 
Cerebral Metabolic Rate of Oxygen Consumption in Humans during 
Rest and Hypercapnia  
 
4.1 Abstract  
The effect of hypercapnia on cerebral metabolic rate of oxygen consumption (CMRO2) 
has been a subject of intensive investigation and debate. Most applications of 
hypercapnia are based on the assumption that a mild increase in pCO2 has negligible 
effect on cerebral metabolism. In this study we sought to further investigate the vascular 
and metabolic effects of hypercapnia by simultaneously measuring global venous oxygen 
saturation (SvO2) and total cerebral blood flow (tCBF) with a temporal resolution of 30s 
using MR susceptometry and phase-contrast techniques in ten healthy awake adults. 
While significant increases in SvO2 and tCBF were observed during hypercapnia 
(p<0.005), no change in CMRO2 was noted (p>0.05). Additionally, fractional changes in 
tCBF and end tidal CO2 (R2 = 0.72, p<0.005), as well as baseline SvO2 and tCBF (R2 = 
0.72, p<0.005), were found to be correlated. The data also suggested a correlation 
between cerebral vascular reactivity (CVR) and baseline tCBF (R2 = 0.44, p = 0.052). A 
CVR value of 6.1 ± 1.6 %/mm of Hg was determined using a linear fit model. 
Additionally, an average undershoot of 6.7 ± 4 % and 17.1 ± 7 % was observed in SvO2 
and tCBF upon recovery from hypercapnia in six subjects. 
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4.2 Introduction  
Carbon dioxide (CO2) is a byproduct of oxidative metabolism and is an important 
cellular signaling molecule in all organisms. The arterial partial pressure of carbon 
dioxide (pCO2) is one of the major regulators of cerebral circulation. Increased pCO2 
(hypercapnia) causes vasodilatation that, in turn, results in a drop in vascular resistance 
and a concomitant increase in cerebral blood flow when autoregulation pathways are 
intact [124]. Carbon dioxide likely mediates its effects by lowering perivascular pH 
which, in turn, is known to drive vascular tone. However, the exact mechanism by which 
this modulation occurs, is not completely understood [125]. 
Since hypercapnia is a common pathophysiologic condition accompanying 
various cardio-respiratory diseases (e.g. chronic obstructive pulmonary disease, 
hypoventilation syndromes), understanding its effects on cerebral blood flow and 
metabolism are of pivotal clinical importance. The effect of hypercapnia-induced 
hyperperfusion is used as a diagnostic tool to measure cerebrovascular reactivity (CVR), 
providing information on the integrity of cerebral autoregulation and is used to assess 
intracerebral hemodynamics [126]. CVR also serves as a predictor of cerebrovascular 
disease progression [127] and its impairment is regarded as a risk factor for future 
vascular events such as stroke.  
While the vascular effects of hypercapnia on cerebral blood flow have long been 
recognized [13], its effects upon central nervous system activity and cerebral metabolism 
are not well established.  Diagnostic and experimental applications of hypercapnia to the 
study of CVR are based on the assumption that mild alterations of pCO2 have negligible 
effect on cerebral metabolism.  
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The first quantitative report of the effect of hypercapnia on CMRO2 which 
appeared almost 60 years ago suggested conservation of cerebral metabolism upon 
inhalation of 5-7% CO2 [13]. Since then numerous groups have investigated neuronal and 
metabolic implications of hypercapnia and reported a wide spectrum of responses ranging 
from increase [10 ], decrease [11 , 128] and stasis of CMRO2 [12-14].Electro-
physiological studies investigating the effect of hypercapnia have not been conclusive 
either, with results ranging from extreme cortical depression to extreme arousal (with 
some even reporting seizures) [129]. Differences in methodologies such as strength and 
duration of CO2 stimulus, use of anesthetic agents, and species studied, etc., have 
confounded direct comparison and interpretation of these results. 
Even though there is no complete consensus regarding the metabolic effects of 
hypercapnia, constant CMRO2 is often assumed during increased pCO2 for normalizing 
blood oxygen-level dependent (BOLD) response in functional magnetic resonance 
imaging (fMRI) [8-9].  The functional BOLD effect (increase in signal amplitude during 
functional activation due to decreased transverse relaxation rate, R2*) is a complex 
function of CBF, CBV and CMRO2. With the assumption of constant CMRO2, the 
decrease in R2* during hypercapnia results solely from an increase in CBF and 
commensurate reduction in oxygen extraction fraction. On the other hand, functional 
activation paradigms, such as visual stimulation, have been shown to cause a smaller 
relative decrease in R2*, the difference being ascribed to greater oxygen extraction due to 
increased CMRO2 [9]. Hence, hypercapnia has been used to “calibrate” BOLD signal 
against purely hemodynamic effects without concomitant metabolic changes.  
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The primary motivation for the present research was to further elucidate the effect 
of hypercapnia on CMRO2 using a more advanced methodology. The current work builds 
on the work presented in Chapter 2 for simultaneously measuring venous oxygen 
saturation (SvO2) and total cerebral inflow (tCBF) to ensure efficient, accurate and 
reliable CMRO2 quantification with a temporal resolution of about two measurements per 
minute. The method measures venous blood oxygen saturation in the superior sagittal 
sinus (SSS) via MR susceptometry, yielding the intravascular bulk magnetic 
susceptibility relative to surrounding tissue, and simultaneously measures arterial flow in 
the major inflow vessels (internal carotid and vertebral arteries) by phase-contrast MRI. 
 
4.3 Methods 
Ten nonsmoking, healthy volunteers (males, age: 28 ± 5 years) were recruited for 
the study after giving informed consent. The subjects were judged to be healthy on the 
basis of their medical history and physical examination. The particular population 
demographic was chosen to ensure maximal subject compliance to the hypercapnia 
challenge protocol. The protocol was approved by the Institutional Review Board of 
University of Pennsylvania.  
 
4.3.1 Stimulus Protocol 
Moderate hypercapnia was induced by administering 5% CO2 gas mixed in room 
air (20% O2; 75% N2) through a 100L Douglas bag to allow resistance-free supply of air 
via a mouthpiece. A closed loop was formed between the subject’s lungs and the 100L 
Douglas bag, which was accomplished by employing a nose clip and having the subjects 
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inhale and exhale from and into a large-diameter short-length tube attached to the 
Douglas bag. The concentration of gases being exhaled into the Douglas bag (5-6%) thus 
approximately matched that in the bag. Additionally, the small volume of exhaled air 
rapidly equilibrated with the substantially large volume of the Douglas bag, thereby 
causing negligible change in the FiCO2 (inspired CO2) delivered throughout our 
experimental paradigm. The capnometer (Precess, Invivo, Orlando, FL) for end-tidal CO2 
(EtCO2) sampling was attached to the above mentioned mouthpiece tubing. Additionally, 
heart rate and arterial oxygen saturation (SaO2) were monitored throughout the 
experiment using a digital pulse oximeter (Precess, Invivo, Orlando, FL). The paradigm 
consisted of three phases: normocapnia (baseline), hypercapnia and normocapnia 
(recovery) for durations of 3, 3, and 5 minutes, respectively. For the hypercapnic 
stimulus, a duration of 3 minutes was chosen to be comparable to the duration employed 
in previous MRI studies [12, 130]. Additionally, a 3mL venous blood sample was drawn 
from the antecubital vein of the subjects to determine hematocrit (Hct), hemoglobin 
(Hgb) and mean corpuscular hemoglobin concentration (MCHC) (constants used in the 
computation of HbO2) on the day of the MRI exam. 
 
4.3.2 MR Protocol 
An interleaved gradient-echo pulse sequence was used for simultaneous 
measurement of SvO2 and tCBF at two different anatomic locations. Specifically, SvO2 
was quantified at the level of superior sagittal sinus (SSS) using MR-susceptometry based 
oximetry and tCBF was determined in the internal carotid and vertebral arteries via PC 
MR. Additional details on the pulse sequence can be found in chapter 2.   
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Images were acquired on a 3T Siemens Tim Trio system (Siemens Medical 
Solutions, Erlangen, Germany) using a 12-channel head and neck coil. A vendor 
provided sagittal FLASH (fast low angle shot) sequence was used to obtain an angiogram 
of head and neck vessels. The sequence is based on a fast rephased-dephased gradient 
echo sequence and generates two echoes per excitation to provide images where static 
tissue is eliminated while signal from flowing blood is preserved. Sequence parameters: 
280x280, resolution: 1.5x1.5x40 mm, slices = 3, TR=38ms, TE=7.2ms, flip angle=15, 
total scan time= 22 s. This, in conjunction with gradient echo axial localizer scans was 
used to choose the straightest section of vessels of interest (SSS, internal carotid and 
vertebral arteries) and estimate the tilt angle  of the SSS with respect to B0 from the 
coordinates of the centroid of the vessel (z ~ 4 cm ) [44]. 
Scan parameters: Voxel size = 1  1  5 mm3, flip angle = 25°, TR=35ms, echo 
spacing = 3.5ms for SvO2 quantification and voxel size = 0.85  0.85  5 mm3, VENC = 
60cm/s (normocapnia) and 100 cm/s (hypercapnia) for tCBF quantification, total scan 
time = 28s. Additionally, a T1-weighted 3D magnetization-prepared rapid gradient-echo 
image dataset (voxel size = 1 x 1 x 1 mm3) was used to estimate intracranial volume [82]. 
Total brain volume was obtained using a semi-automated region-growing algorithm 
(ITKSnap; [87]).  
It is noted that that the typical tilt angles of SSS in our study were <15.  Since the 
induced field outside a cylinder falls off as the inverse square of the distance and the 
square of the sine of the tilt angle (Equation 1.3) [131], the magnetic field outside the 
SSS was negligibly perturbed (note in Fig. 2 c-e the sharp drop in the net accumulated 
phase outside the SSS and the near constancy of the field in the reference tissue). An ROI 
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was chosen within the SSS and in the surrounding homogenous brain tissue at a distance 
on the order of the diameter of the vessel and  was calculated by subtracting the net 
accumulated phase in the two regions.  
A linear model for cerebral vascular response to hypercapnia was assumed and 
CVR was estimated as the slope of the %tCBF versus EtCO2 curve. Analysis of 
Variance (ANOVA) was used to test for differences in group means of SvO2, tCBF and 
CMRO2 between the three test conditions (baseline, hypercapnia and recovery).    
 
 
 
 
 
 
 
4.4 Results 
Inhalation of 5% CO2 gas mixture produced similar changes in EtCO2 across all 
subjects. Figure 4.1 shows the time course of various physiological parameters in one of 
the subjects (heart rate, SaO2 and EtCO2) recorded during the experiment. Group means 
for all subjects are listed in Table 4.1. Figure 4.2 displays magnitude and phase 
difference images at the level of the SSS (Figures 4.2b-e) and velocity maps of the neck 
Figure 4.1:  Time course plots of various physiological parameters: heart rate 
(HR), arterial oxygen saturation (SaO2) and end-tidal CO2 (EtCO2) during 
baseline, hypercapnia (shaded; 5% CO2) and recovery in a representative 
subject. 
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vessels (Figures 4.2f-i). Notice the expected decrease in phase contrast for the SSS, 
indicating increased SvO2 levels and the enhanced blood velocity in neck vessels during 
hypercapnia.  
 
 
 
 
 
 
 
 
 
 
 
The initial tCBF and SvO2   response to hypercapnia is estimated to be less than 
30s, consistent with previously reported results. The response stabilized after ~1-2 
minutes for all subjects (Figure 4.3).  Additionally, an average undershoot of 6.7 ± 4 % 
Figure 4.2: Images from which venous oxygen saturation (SvO2) and total cerebral blood (tCBF) 
flow during baseline, hypercapnia and recovery was derived ( a) Sagittal localizer angiogram 
indicating the locations for SvO2 (top) and tCBF (bottom) measurements;( b) axial magnitude; (c-e) 
phase difference images for SvO2 quantification highlighting SSS; (f) axial magnitude and (g-i) 
velocity images of the neck showing the major cerebral inflow vessels (internal carotid and vertebral 
arteries). Note the change in contrast in vessels during hypercapnia.  
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and 17.1 ± 7 % was observed in SvO2 and tCBF values upon recovery from hypercapnia 
in six subjects (Figure 4.3). 
The group averages for the various measured parameters during the three 
experimental conditions are given in Table 4.1. A significant linear correlation was 
observed between % tCBF and EtCO2 (R2=0.72; p<0.005), and CVR, computed as the 
slope of the above curve, was 6.1 ± 1.6 %/mm Hg (Figure 4.4a). Further, CVR was 
negatively correlated with baseline tCBF, even though this relationship was only 
marginally significant (R2=0.44; p=0.052; Figure 4.4b). Baseline SvO2 and tCBF were 
correlated as expected (R2=0.72; p<0.005; Figure 4.4c).  Finally, significant changes in 
both SvO2 and tCBF were observed during hypercapnia (both p<0.005, Figures 4.5a, b), 
whereas global CMRO2 remained unchanged (p = 0.78, Figure 4.5c). 
 
 
 
Figure 4.3: Plot of time-resolved measurements of tCBF and SvO2 during normocapnia 
and hypercapnia (shaded) in a representative subject. Note the undershoot during 
recovery from hypercapnia. 
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4.5 Discussion 
The effect of increased blood CO2 on neuronal activity and cerebral oxidative 
metabolism has been a subject of intensive investigation during the past six decades. In 
this study we report simultaneous measurement of metabolic (SvO2) and hemodynamic 
(tCBF) parameters in response to mild hypercapnia (5% inspired CO2), in healthy, awake, 
adult subjects by means of quantitative MRI.  Our results support the notion of negligible 
change in CMRO2 with a mild hypercapnic stimulus. Previous human studies with 
different methodologies, but also invoking Fick’s principle for CMRO2 quantification 
[12-14], as well as in vivo small animal studies measuring neuronal metabolites of 
oxidative phosphorylation (ATP, ADP and AMP), have reported similar results upon 
exposure to mild hypercapnia [132, 133 ].  
 
 
 
 
 
 
 
Figure 4.4: (a) % change in tCBF (tCBF) vs. change in EtCO2 (EtCO2) in response to 
hypercapnia. The slope of the curve represents cerebro-vascular reactivity (CVR); Relationship 
between (b) inter-subject CVR and baseline tCBF and (c) Baseline SvO2 vs. tCBF.  
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In distinction to prior work, our experimental approach allows for rapid, 
simultaneous measurement of SvO2, tCBF and EtCO2. The ability to simultaneously 
quantify two key parameters in Fick’s equation gives us particular confidence in the 
veracity of our CMRO2 estimates as opposed to all prior work requiring sequential 
measurements[12, 128]. Additionally, our method enables point-by-point temporal 
analysis of vascular and metabolic responses to hypercapnia with a temporal resolution of 
30 seconds. This improves the experimental sensitivity to visualize short time scale 
responses to pCO2 changes (for example, detection of temporal lags in achieving a steady 
state response due to abrupt induction and cessation of hypercapnia).  Even the most 
recently conducted hypercapnia studies have precluded such an evaluation [12, 128].  
The observed experimental CVR value of 6.1 ± 1.6 %/mm Hg,  obtained using a 
linear-fit model, is in the range of previously reported values (4-7 %/mm of Hg) [12, 134-
135]. The between-subject variability of ~21% in the individual CVR measurements is in 
good agreement with coefficients of variation reported previously [136-137]. While the 
underlying mechanism for this variation in CVR is not fully understood, we conjecture 
that it might be explainable, at least in part, by inter-subject variations in baseline tCBF. 
Support for such an interpretation is the observation of a moderate negative correlation, 
approaching statistical significance, between vascular response to hypercapnia (CVR) and 
baseline tCBF (R2 = 0.44, p = 0.052). This association suggests that the capacity for 
vasodilatation by a hypercapnic stimulus might be a function of baseline cerebral flow. A 
similar negative correlation (though not statistically significant) between regional 
cerebral vascular response to hypercapnia and baseline CBF values in the occipital cortex 
had been noted in a PET based study by Ito et al. [138]. 
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Of interest, our experimental data demonstrates concordance with many known 
principles of human physiology. For example, a strong positive correlation was observed 
between baseline SvO2 and tCBF, analogous to prior reports by Xu et al [56], and as 
illustrated earlier in Chapter 2 . Under stable resting cerebral physiologic conditions, 
changes in flow are unlikely to change the rate of metabolism. This concept is based on 
the assumption that in a resting awake healthy human brain the metabolic demand should 
be constant [139].  As expected during hypercapnia, the observed increase in SvO2 was 
Figure 4.5: Scatter plot of functional parameters for all subjects during baseline, 
hypercapnia (shaded) and recovery  (a) tCBF;  (b) SvO2; (c) CMRO2 .The vertical span of 
each diamond represents the 95% confidence interval of the group means (CI), symbols refer 
to individual subjects. 
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accompanied by a commensurate increase in tCBF suggesting cerebral activity to remain 
invariant.  
Our data indicate that the steady-state tCBF hypercapnic response is attained with 
some delay. Prior work has shown that the bulk of this delay is caused by the time 
required for the build-up of CO2 in arterial blood; which in turn is a function of the level 
of ventilation, CO2 diffusion time and pulmonary blood flow [140-141]. However, 
studies have also noted that tCBF equilibration lags behind arterial pCO2 stabilization. 
Therefore, we posit that the delay we observed might also be due to CO2 mediating its 
physiologic effects via alterations in perivascular pH.  Many animal studies have noted 
that decreases in pH result in vasodilatation and, conversely, increases cause 
vasoconstriction.  These effects have been thought to be mediated by secondary 
messengers regulating smooth muscle vascular tone [142 ].  
 
In our experimental paradigm it is plausible to assume that as arterial pCO2 
increases during presentation of the hypercapnic stimulus, CO2 diffuses into the brain 
parenchyma, eventually attaining a steady-state value.  The initial changes in pH are 
likely offset, at least in part, by local tissue buffering at the intra- and extra-cellular level 
[143]. However, as the hypercapnic stimulus persists and the steady-state parenchymal 
Table 4.1: Summary of various measured parameters 
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pCO2 value is reached, these local homoeostatic measures are overwhelmed. The ensuing 
decrease in pH likely then triggers the production of secondary intracellular mediators at 
end arterioles, thereby lowering cerebral vascular resistance and producing the observed 
increase in blood flow [124]. As these events depend on a series of processes occurring, it 
is reasonable to assume that the observed steady-state response would develop over a 
period of minutes rather than instantaneously. In our study the initial changes in cerebral 
blood flow were observed in less than 30 seconds; however, the time to achieve steady-
state CBF was on the order of 1 - 2 minutes. These time scales are consistent with 
previous reports [140-141, 144].  
We also noted an average of 17% decrease in CBF below the baseline after 
cessation of the hypercapnic stimulus in six of the ten subjects (Figure 4.3). Other 
investigators have also reported similar undershoots in tCBF during recovery from 
hypercapnia. Previous work by Poulin et al. and Claassen et al. [144-145], using 
transcranial doppler ultrasound,  as well as more recent work by Chen et al. [12], using 
arterial spin labeling (ASL), indicate similar trends in tCBF data.   
Although the exact physiological mechanism of this undershoot in CBF is 
unclear, we hypothesize that this response might have been mediated by a combination of 
rapid respiratory egress of pCO2 via hyperventilation, in conjunction with a slower re-
equilibration of cellular buffering mediators (such as tissue bicarbonate and inorganic 
bases).  So, even after cessation of the hypercapnic stimulus, arterial pCO2 likely remains 
above the normal physiologic range. This interpretation is supported by the presence of 
transiently elevated EtCO2 (above baseline) even upon abrupt removal of the hypercapnic 
stimulus. Consequently, hyperventilation would persist as central pH sensitive 
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chemoreceptors in the respiratory centers of the pons and medulla, as well as peripheral 
receptors for pH and CO2 in the carotid and aortic bodies continue to fire [146]. 
However, as the respiratory clearance of CO2 quickly ensues [140-141], the cellular 
chemical buffering mediators (initiated at the onset of hypercapnia) are likely to take 
longer to equilibrate, resulting in a brief period of tissue alkalosis. The proposed brief 
period of tissue alkalosis during recovery from hypercapnia has also been reported in a 
31P-NMR based rat study [147]. This transient increase in pH may produce 
vasoconstriction at local end arterioles resulting in the observed undershoot in tCBF. It is 
noted that hyperventilation induced hypocapnia is unlikely to be the reason for the 
observed undershoot as a similar trend in EtCO2 data was not observed.  
 As pointed out earlier, numerous studies have investigated the vascular, neuronal 
and metabolic implications of hypercapnia. While a review of the hypercapnia literature 
in its entirety is beyond the scope of the current article, two recent studies utilizing MRI-
based methods for CMRO2 quantification and a study protocol somewhat similar to ours 
are of particular relevance, even though they are based on a different methodology for 
quantifying SvO2 and flow. Our results are in good agreement with those reported by 
Chen and Pike [12].  Specifically, they reported a conservation of CMRO2 during mild 
hypercapnia and a CVR value very similar to ours (5.9 vs. 6.1). Additionally, an 
undershoot in tCBF values was also observed in the presented tCBF time series plots. 
However, our results are at variance with those reported by Xu et al. [128], who observed 
a decrease in CMRO2 during hypercapnia with the effect being dose dependent.   
A few methodological differences could potentially have contributed to the 
discrepant results. Typically, including in our study, CMRO2 is calculated as the product 
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of whole brain blood flow and difference in oxygen saturation between arterial and SSS 
blood. However, Xu et al. measured CBF in the superior sagittal sinus as representative 
of tCBF.  Under physiological alterations such as hypercapnia, flow through the SSS 
would be a valid alternative for tCBF as long as the proportion of cerebral venous 
drainage remained constant. However, it is conceivable that in order to accommodate the 
dramatic increases in flow prompted by hypercapnia, other venous conduits might be 
recruited beyond the SSS. It is noted that the cerebral venous system is valveless; and 
several routes for drainage exist. The extent of venous drainage might vary under 
physiological challenges as the cerebral veins and sinuses are low compliance vessels 
with a fixed capacity for drainage. Hence, there might be great variability in distribution 
of venous return when faced with increases in cerebral blood flow such as the present 
experimental paradigm. The above could lead to underestimation of flow changes in 
response to hypercapnia when approximating tCBF from a measurement in the SSS.   
We note that quantification of SvO2 in the SSS as representative of global SvO2 to 
be of lesser concern. PET data demonstrated little inter-regional variation in venous 
oxygen saturation during resting conditions in human subjects. Hence the SSS, which 
receives a large portion of the cerebral venous drainage, is likely to be a good indicator of 
global venous oxygen saturation [148].  Direct spectrophotometric measurements in 
anesthetized cats have given similar results [133].  
While our experiment lends support for negligible change in CMRO2 in response 
to hypercapnia, our measurements do not preclude the possibility of regional variations in 
CMRO2. In fact, evidence for such regional heterogeneities in neuronal response to 
hypercapnia have been reported previously [12, 149-150]. Such observations 
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withstanding, we sought to evaluate only global metabolic response to hypercapnia in our 
experiment. Additionally, we investigated only the effects of mild and acute exposure to 
increased CO2 levels. It is probable that a stronger hypercapnic stimulus, or a longer 
exposure might alter the CMRO2.There is some evidence for such CMRO2 changes based 
on pervious animal studies [151 ]. Lastly, it is possible that the small population size 
studied might have limited our ability to evaluate changes in CMRO2 in response to 
hypercapnia. However, while designing the study our analysis indicated that a subject 
size (N) of 10 would allow detection of 7-8 % relative difference in any of the measured 
parameters, with 80% power and 5% significance. Reproducibility of CMRO2 at 3T was 
previously found to be on the order of 8 % [120].  
In summary, this study sought to investigate the effect of mild hypercapnia (~9 
mm Hg) on global CMRO2 by simultaneously measuring tCBF and global SvO2. The 
simultaneous measurement scheme is likely to improve accuracy and reliability of 
measuring CMRO2 as opposed to performing sequential measurements. Additionally, the 
achieved temporal resolution (~0.5 min.) allows probing the temporal dynamics of 
vascular and metabolic effects of hypercapnia.  
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Chapter 5: MRI based Quantification of Global Cerebral Metabolism in 
Neonates with Congenital Heart Disease 
 
5.1 Introduction 
Various forms of congenital heart diseases (CHD) affect approximately 35,000 
infants each year in the United States (2006). These patients suffer both short-term and 
long-term neurological consequences due to their heart defect and as such have immature 
brain development for their gestational age. Seizures, strokes, hemorrhages, and 
periventricular leukomalacia (PVL) are observed in a large fraction of these patients post-
operatively [152-154].  Long term, 5 to 25% of the survivors of infant heart surgery 
suffer from diminished cognitive performance, developmental delays, attention deficit 
hyperactivity disorder, seizures and cerebral palsy [155-159] and about 50% require some 
form of academic support in school while 15% are in full-time special education 
classrooms [160-161].  
 
5.1.1 Brain Injury and Baseline Hemodynamic Parameters 
Periventricular leukomalacia (PVL) is the most common cerebral injury present in 
this population. This type of injury is typically seen in premature infants and is 
characterized by focal necrosis in the periventricular region, with diffuse white matter 
injury, pyknotic glial nuclei and reactive gliosis [162-163]. In premature infants, the 
greatest risk period for this injury is when oligodendrocyte precursors are proliferating 
and differentiating (before the process of myelination initiates).   
During the early stages of brain development, these oligodendrocyte precursors 
are very metabolically active and highly susceptible to injury from reduced blood flow 
  
 
72
and oxygen delivery. Hence ischemia has been implicated as a major cause of peri-natal 
white matter damage. This hypoxic white matter injury leads to impaired myelination and 
has been postulated to underlie, at least in part, impaired cognition and cerebral palsy 
commonly seen in this cohort [158, 164-166].  
The exact reasons for this type of white matter injury (PVL) in neonates with 
congenital heart malformations are even less clear. Studies have shown that hypoxia, 
hypocarbia and hypotension due to congenital cardiac malformations are associated with 
the development of PVL [153, 167-168]. Additionally, a circulatory system with 
immature or absent cerebral autoregulation has also been indicated to play a significant 
role [169].  The effect of periopertive risk factors such as high base deficit during 
cardiopulmonary bypass (CPB), deep hypothermia and total circulatory arrest (DHCA) 
[168] has also been investigated. However, the results have been unclear and a substantial 
percentage of children are found to have cognitive impairments and neurological deficits 
regardless of the type of cardiopulmonary bypass treatment [156, 158, 170-171]. 
Additionally a large percentage of newborns with CHD are found to have 
neurodevelopmental abnormalities before surgery, sometimes in the absence of overt 
lesions on structural Magnetic Resonance Imaging (MRI) cerebral exams [172].  
Quantifying the hemodynamic and metabolic state of these neonates before and 
after surgery would be valuable in gaining a better understanding of the interaction of 
their CHD physiology on their cerebral health and potentially predict and prevent adverse 
outcomes in the form of brain injury. 
  
5.1.2 Hypercapnia 
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Historically, it has generally been assumed that cerebral metabolism (CMRO2) 
does not change during hypercapnia (as illustrated in Chapter 4). However, it is plausible 
that in situations where cerebral metabolism is limited due to hypoxia and low cerebral 
blood flow (as is the case in neonates with CHD) a vasoldilatory stimulus like 
hypercapnia might be of some therapeutic value. In fact, Jankov et al. showed that 
hypercapnia improved both CBF and cerebral metabolism in immature rats suffering 
from hypoxic-ischemic brain injury. Mild hypercapnia has therefore been suggested 
during the pre-operative intensive care management of these high risk neonates [173] in 
order to improve cerebral blood flow, oxygen delivery, oxygen consumption and hence 
neurological outcomes. Thus evaluating hemodynamic parameters such as blood flow, 
oxygenation and cerebral metabolism in response to hypercapnia will be of significant 
clinical value in designing strategies for preoperative management of these patients. 
Very few modalities exist to monitor hemodynamic and metabolic parameters in 
these neonates. Most studies evaluating global cerebral oxygenation have relied on 
invasive blood draws from large arterial and venous vessels. Near infrared spectroscopy 
(NIRS) has emerged as a primary modality to assess microvascular oxygen saturation. 
The biggest advantage of the method is the ease of acquisition and capability for bedside 
monitoring. However, NIRS measures tissue oxygen saturation which represents a 
weighted mixture of arterial (~25%) and venous (~75%) oxygen saturation (Watzman, 
Kurth et al. 2000). Methods for measuring blood flow are equally scarce and fraught with 
several challenges. NIRS based methods infer CBF from changes that occur in total 
hemoglobin concentration (or blood volume) and are limited to quantifying only relative 
changes in response to a stimulus. Quantitative measurement of absolute CBF is also 
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challenging. Several groups have used Transcranial Doppler (TCD) ultrasound to 
measure velocity in cerebral vessels. However, blood velocity does not give direct 
information on CBF and estimation of vessel cross sectional area is difficult, especially in 
newborns, using ultrasound due to poor spatial resolution. Additionally, it is highly 
dependent on the technical skills of the user.  
In this study we use the previously described (Chapter 2) non-invasive method for 
simultaneously measuring global bi-hemispheric cerebral venous oxygen saturation and 
blood flow to assess the cerebral health of neonates afflicted with complex CHD, at rest 
and in response to hypercapnia. The method measures venous blood oxygen saturation in 
the superior sagittal sinus (SSS) via MR susceptometry, yielding intravascular bulk 
magnetic susceptibility relative to surrounding tissue, and simultaneously measures 
cerebral flow in the major inflow and outflow vessels (common carotid arteries and SSS) 
by phase-contrast MRI. These measurements were performed pre and post operatively to 
assess if the acquired parameters predict pre/post-operative injury in these neonates. 
Additionally changes in cerebral oxygenation, flow and metabolism in response to a 
hypercapnic challenge were evaluated with a two-fold objective; first to test the 
hypothesis that hypercapnia increases cerebral metabolism in neonates with complex 
CHD ; and secondly to cross validate MR-based hemodynamic measurements with more 
clinically widespread optical techniques (NIRS and DCS hybrid method).  
 
 5.2 Study Population  
Our clinical studies focus on two main heart defects: Transposition of the Great 
Arteries (TGA) and Hypoplastic Left Heart Syndrome (HLHS). These heart lesions are 
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dependent on a patent ductus arteriosus (shunt connecting the pulmonary artery and 
aorta) and an atrial septal defect (shunt connecting left and right atria) for mixing of 
systemic and pulmonary venous blood to provide oxygenated blood to the brain and the 
body. Additionally, for survival these defects require surgical repair (TGA) or palliation 
(HLHS) within the first week of life.  
 
5.2.1 Physiology of the Healthy Heart 
In a healthy heart, the right side of the heart pumps deoxygenated blood to the 
lungs for re-oxygenation, while the left side of the heart pumps oxygenated blood to the 
brain and body. Deoxygenated (venous) blood returns from the brain and body to the 
right atrium and is pumped to the lungs from the right ventricle via the pulmonary 
arteries.  Oxygenated blood then returns from the lungs to the heart via the pulmonary 
veins into the left atrium, passes to the left ventricle, and is then pumped through the 
aorta into systemic circulation.   
 
5.2.2 Hypoplastic Left Heart Syndrome (HLHS) 
HLHS is a particularly severe form of CHD characterized by an underdeveloped, 
or hypoplastic left ventricle and stenosed or atretic mitral and aortic valves.  
Due to the lack of blood flow out of the left side of the heart, the aortic valve and the 
ascending aorta becomes hypoplastic or atretic.  These malformations are fatal if not 
corrected and require surgery within the first week of life.   
Palliative cardiac surgery for HLHS is performed in a series of three stages.  In 
this approach, the hypoplastic left ventricle is eliminated from the circulation and the 
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right ventricle becomes the systemic pumping chamber. All patients included in our 
studies undergo the first stage of surgery, known as the Stage I/Norwood procedure.  The 
goal of the Norwood procedure is to build a new aorta (“neoaorta”) to carry blood to the 
body, brain, and lungs.  
The “neoaorta” is constructed from the atretic ascending aortic arch and the 
common pulmonary artery which is disconnected from the branch pulmonary arteries. An 
artificial shunt is then connected to the first vessel that arises from the aorta (usually the 
innominate artery) with the other end connected to the branch pulmonary arteries to 
provide adequate blood flow to the lungs. Since the left ventricle is inadequate in size (or 
there is no left ventricle at all), the right ventricle serves as the systemic ventricle to 
pump blood through the new outflow tract. Additionally, the arterial septum is excised 
creating a large inter-atrial communication to allow for unrestricted flow out of the left 
atrium and provide adequate mixing of oxy/deoxygenated blood within the right atrium.   
For the procedure, patients are first anesthetized (isoflurane, fentanyl, 
pancuronium) and orally intubated. They are then cooled to approximately 25 to 28°C 
and placed on cardiopulmonary bypass, whereby a cannula is placed in the aorta and in 
the right atria to bypass the heart.  The heart is then transiently stopped to perform the 
remainder of the surgical procedure.  The patient is cooled further to 18 to 20°C, and the 
heart is isolated from the rest of the body by clamping the pulmonary artery.  Deep 
hypothermic circulatory arrest is maintained for approximately 45 to 60 minutes to 
complete the surgical procedure, at which time the patient is re-warmed to 34°C and 
finally separated from cardiopulmonary bypass.    
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5.2.3 Transposition of Great Arteries 
As the name suggests, TGA involves transposition of the aorta and the pulmonary  
artery. It is a ventriculoarterial discordant lesion, in which aorta arises from the right 
ventricle and pulmonary artery from the left ventricle. These malformations are typically 
repaired during the first few days of the first week of life in order to preserve the left 
ventricle’s ability to support systemic circulation.  
Surgical repair to correct for TGA is called the Arterial Switch Operation (ASO).   
ASO involves transaction of both great arteries, and then translocation of the vessels to 
the opposite root, thereby creating ventriculoarterial concordance (aorta to left ventricle, 
and pulmonary artery to right ventricle). Patients are first anesthetized (isoflurane, 
fentanyl, pancuronium) and orally intubated.  Then they are cooled to approximately 25 
to 28°C and placed on cardiopulmonary bypass (a cannula is placed in the aorta and in 
the right atria to bypass the heart).  The aorta and pulmonary arteries are clamped off and 
then detached and finally reattached in the correct manner. The coronary arteries are 
excised from the aorta above the right ventricle and mobilized to the left ventricle 
outflow track. The patient is then re-warmed to 34°C and separated from 
cardiopulmonary bypass.   
 
5.2.4 Other Diagnosis 
A small segment of our population included two other CHD diagnosis: Tetrology 
of Fallot and heterotaxia. Tetrology of Fallot is the most common form of cyanotic 
congenital heart disease and involves a tetrad of cardiac abnormalities: (i) ventricular 
septal defect with (ii) over-riding aorta, (iii) right ventricular outflow obstruction and (iv) 
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right ventricular hypertrophy. Tetrology is regarded as a family of diseases, all 
characterized by a similar intracardiac cardiac anatomy but highly variable in terms of 
pulmonary artery anatomy, and hence associated abnormalities and outcomes.  
Heterotaxy comprises a broad spectrum of abnormalities all characterized by left-
right asymmetry. In this syndrome, paired organs, such as the lungs or kidneys, are often 
mirror images of one another instead of having their intended unique characteristics. In 
milder cases there is some left-right asymmetry, which can be discordant from organ to 
organ or even within the organ itself. In severe cases there is complete failure to develop 
asymmetry and can lead to complex abnormalities of systemic and pulmonary drainage, 
along with malposition of the great vessels (pulmonary artery and aorta) and sub-
pulmonary and aortic obstructions. Overall the prognosis of neonates with severe 
heterotaxy is poor. 
 
5.3 Methods 
All full-term newborn infants with complex CHD admitted to the cardiac 
intensive care unit at The Children’s Hospital of Philadelphia were screened for 
participation in this study (approved by Institutional Review Board). Inclusion criteria 
included full  
term age (gestational age 40 ± 4 weeks), an intention  to undergo surgery with  
cardiopulmonary bypass (CPB) with or without deep hypothermic circulatory arrest  
(DHCA), medical stability for 24 hours prior to surgery, and a diagnosis of CHD on 
admission. Exclusion criteria included: small for gestational age (< 2 kg), a history of 
neonatal depression (5 minute APGAR (Appearance, Pulse, Grimace, Activity, 
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Respiration) score < 5 or umbilical cord pH < 7.0), or evidence of other end-organ 
dysfunction.  In addition, subjects who had experienced pre-operative cardiac arrest 
requiring chest compressions, and subjects with HLHS who had been clinically treated 
with hypercarbia (increased inhalation of CO2) for over-circulation to the lungs were 
excluded from the study. 
 
 
 
 
 
The study was performed on the morning of the patient’s scheduled cardiac 
surgery and the patient was anesthetized and intubated either in the cardiac operating 
room or the cardiac intensive care unit. Sedation and neuromuscular blockage were 
maintained with 5-10 μg/kg fentanyl and 0.2 mg/kg pancuronium, respectively. The 
patient was kept mechanically ventilated. Additionally, arterial and venous lines for 
obtaining blood gases were placed (if not placed already).   
Baseline absolute optical property measurements were made while obtaining 
vascular access once the patient was sedated. Patients were then brought to the MRI 
scanner and another non-invasive optical probe was placed on the forehead for 
continuous optical monitoring. After a 30-minute baseline period of ventilation with FiO2 
Figure 5.1: Timeline of the study participation. “0” represents time point right after surgery. Pre-
operative MRI was conducted before surgery and included a 30 minute hypercapnic episode. Post-
op MRI scans were performed 3-7 days after surgery.  
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(fraction inspired oxygen) of 0.21, CO2 was added to the room air mixture to achieve a 
FiCO2 of approximately 0.04.  The CO2 mixture remained on for a 30-minute 
hypercapnic period to allow for gas equilibration. The MRI and the optical measurements 
were acquired simultaneously at the end of this 30-minute hypercapnic period. During the 
period of equilibration, an anatomic brain MRI was obtained.  Non-invasive cuff blood 
pressures, electrocardiogram, peripheral oxygen saturation, and FiCO2 were monitored 
and recorded throughout the duration of the study.  Arterial blood gases were obtained at 
the start of the baseline period and at the end of the hypercapnia period to assess changes 
in the partial pressure of carbon dioxide (pCO2) in the blood.  
Following surgery absolute optical property measurements were obtained for 12 
hours (at 2 hr intervals) after the neonate was brought back to the Cardiac Intensive Care 
Unit (CICU). Postoperative MRI measurements were performed 3-7 days after surgery.   
 
5.3.1 MR Protocol 
A modified version of the interleaved gradient-echo pulse sequence as previously 
described was used for simultaneous measurement of SvO2 in the SSS and CBF in the 
SSS and common carotid arteries. Specifically, SvO2 was quantified using MR-
susceptometry based oximetry and CBF via PC MR as described above.  Additional 
details on the pulse sequence and measurement theory can be found in chapter 2.   
Images were acquired on a 1.5T Avanto MRI system (Siemens Medical Systems, 
Malvern, NJ) using a 12-channel head coil. A gradient echo axial localizer scan was used 
to choose the straightest section of vessels of interest (SSS, common carotid arteries) and 
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to estimate the tilt angle θ of the SSS with respect to B0 from the coordinates of the 
centroid of the vessel (Δz ~ 4 cm ) (Langham, Magland et al. 2009). 
Scan parameters: Voxel size = 1 × 1 × 5 mm3, FOV = 112x112, flip angle = 25°, 
TR = 35ms, echo spacing = 4.16 ms for SvO2 quantification and voxel size = 0.65 × 0.65 
× 5 mm3, VENC = 10 (SSS) and 20 cm/s (CA) during normocapnia and 20 (SSS) and 30 
cm/s (CA) during hypercapnia for CBF quantification, NEX = 3, total scan time ~ 1 min.  
Anatomical MRI sequences included volumetric T1 and T2 SPACE (Sampling 
Perfection with Application optimized Contrasts using different flip angle evolutions) 
sequences acquired in the axial plane and later reconstructed in the sagittal and coronal 
planes. Susceptibility and diffusion weighted imaging sequences were also acquired. A 
clinical neurologist reviewed all images for the presence/absence of new and/or worsened 
PVL. Abnormalities were identified and localized using signal intensity, appearance, 
anatomic location, and diffusion weighted images (indicating acute injury and low water 
motion).    
 
5.3.2 Optics 
As light travels centimeters through the deep tissue, it is multiply scattered in the 
near-infrared spectral region. Additionally, the photons are absorbed in this spectral range 
mainly due to the presence of oxy and deoxyhemoglobin, water and lipids. A detectable 
amount of light scattering comes from red blood cells (RBCs). If the RBCs are moving, 
then the light intensity interference pattern due to photon scattering (i.e. the speckle 
pattern) on the tissue surface will fluctuate in time. The resultant fluctuations of the 
detected intensity can be measured by diffuse correlation spectroscopy (DCS) and can 
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provide information about blood flow. Information about oxygenation level of blood can 
be obtained by using near-infrared spectroscopy (NIRS). This method measures the 
differential change in the transmitted light intensity at multiple wavelengths due to 
absorption and scattering, which in turn depends on the concentrations of oxy and 
deoxyhemoglobin (ΔHbO2 and ΔHb, respectively) among other factors.  
The present study employed a hybrid instrument combining NIRS and DCS [24-
25]. Two separate optical probes were employed in this study. The first probe was 
intended solely for absolute tissue oxygen saturation measurements (StO2) and the second 
to quantify relative changes in oxygenation and blood flow index (BFI) in response to 
hypercapnia (Figure 5.1).  
 
5.3.3 Data Analysis 
We assumed that the SSS drains 60% of the total brain volume in order to convert 
the CBF measurements obtained in SSS to global CBF values [174](also refer to Chapter 
6). Additionally, neonatal brain mass of 300g was assumed to express CBF and CMRO2 
measurements in conventional units of per 100g of brain mass [175]. 
CO2 reactivity was calculated as % ΔCBF (unit-less) divided by ΔpCO2 (mm of 
Hg) in response to hypercapnia. The MRI based measurements of oxygenation (SvO2) and 
flow (CBF) were compared to optical measurements (StO2 and BFI) both at baseline and 
in response to hypercapnia using a linear correlation model. A Wilcoxon matched pair 
test was used to investigate differences in systemic and cerebral hemodynamic 
parameters in response to hypercapnia and post-operatively compared to pre-operative 
baseline levels.  To test for differences in hemodynamic and metabolic parameters in 
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patients with and without brain injury, data was binned according to the presence (>150 
mm3 PVL) and absence of injury and a two-sided Wilcoxon rank sum test was employed. 
A p-value of less than 0.05 was deemed statistically significant.  
 
 
 
 
 
5.4 Results 
A total of 24 patients participated in the hypercapnia part of our study 
(HLHS/TGA/TOF/Heterotaxy = 13/6/4/1).  
 
 
 
 
 
 
 
Table 5.1: Patient demographics summarizing all 24 neonates studied. Data is 
reported as mean ± standard deviation. 
Table 5.2: Median and interquartile range (IQR) of various hemodynamic 
parameters measured pre and post operatively in 8 subjects. The p value 
represents the results of Wilcoxon matched pair test.  
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We obtained post-operative hemodynamic and metabolic measurements in 8 of 
the neonates (HLHS/TGA/TOF/Heterotaxy = 6/1/0/1). Patient demographics are 
summarized in Table 5.1. Patients were born full-term and went to surgery within the 
first week of life.  
 
5.4.1 Baseline Measurements  
Pre-operatively, we observed a significant correlation between age and OEF in 
neonates with HLHS (p<0.0005). OEF, CBF and CMRO2 measurements in the cohort pre 
and post-operatively are summarized in Tables 5.2, 5.3.A statistically significant increase 
in Hb and CMRO2 was observed post-operatively (p = 0.0078, 0.0156) (Table 5.2, 
Figure 5.2(a)). The severity of PVL was found to be associated with absolute post-
operative CMRO2 (p=0.03), in that neonates with lower CMRO2 suffered injury (Figure 
5.2(b)).  
 
 
 
 
 
 
 
Figure 5.2: Box plots demonstrating (a) change in absolute CMRO2 values before and after 
surgery and (b) association of worsened PVL with absolute post-operative CMRO2 value. 
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There was a strong positive correlation between OEF and chronological age in 
neonates with a diagnosis of HLHS (R2=0.56, p<0.005, Figure 5.3). Additionally, we 
observed a significant correlation between MRI based absolute measurements of 
oxygenation and blood flow with optical measurements (R2 =0.64, 0.5; p<0.005, Figure 
5.4).      
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Plot demonstrating the 
correlation between the pre-operative 
baseline OEF with chronological age / day 
of life. 
Figure 5.4: Plots demonstrating correlation between baseline MR and optical measurements 
of oxygenation (a) SvO2 vs StO2 and flow (b) CBF vs. BFI. The dotted gray line represents 
the line of identity.   
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5.4.2 Hypercapnia Measurements  
Average change in pCO2 and CO2 reactivity in response to hypercapnia was 24.9 
± 8.3 mm of Hg and 4.4 ± 2.6 %/mm of Hg, respectively. OEF, CBF and CMRO2 
measurements during baseline and hypercapnia are summarized in Table 5.3. We 
observed a significant increase in CBF (p<0.005) and decrease in OEF (p<0.005) in 
response to hypercapnia. However, no change in CMRO2 was noted (p = 0.909) (Figure 
5.5). Also, MR measured changes in oxygenation and blood flow correlated well with 
optical measurements (R2 =0.68, 0.69; p<0.005; Figures 5.6).     
 
5.5 Discussion  
This work demonstrates the feasibility of MR-susceptometry and phase contrast hybrid 
method to measure absolute blood oxygenation, blood flow and CMRO2 in neonates with 
complex congenital heart disease before and after surgery 
 
 
Table 5.3: Median and interquartile range (IQR) of various hemodynamic 
parameters measured at baseline and in response to hypercapnia in 24 
subjects. The p values were obtained from a Wilcoxon matched pair test.  
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By studying a population of babies with complex congenital heart defects, we were able 
to utilize hypercapnia as a challenge to alter hemodynamics and cross-validate MR based 
measurements against optical measurements. Additionally, absolute normocapnic MRI 
measurements were compared with optical measurements. 
 
5.5.1 Cerebral Oxygenation and Blood Flow Measurements 
MRI offers a robust non-invasive alternative to more invasive blood gas 
measurements, via catheterization, to determine hemodynamic parameters in neonates 
with congenital heart disease. The proposed method measures bi-hemispheric brain 
cerebral hemodynamics and is not limited to a focal region like optical based methods. In 
this investigation, venous oxygen saturation was determined using MR-susceptometry 
based oximetry and blood flow using phase contrast MRI. Both methods have been well 
validated using ex-vivo and in-vivo models (chapter 3). Previous MRI based blood flow 
quantification studies in neonates with congenital heart disease have used an alternative 
technique called arterial spin labeling (ASL) [169]. The major advantage of this method is 
that it provides regional perfusion maps of the brain. However, experience with this 
Figure 5.5: Box plots representing 
the absolute CMRO2 values during 
baseline and in response to 
hypercapnia.  
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method has been somewhat discouraging due to extremely low cerebral blood flows 
encountered in this population [169] leading to significant noise in the measurement. 
Phase contrast MRI can be sensitized to low flows by appropriately choosing the user 
defined parameter VENC. The method has been previously used to measure very low 
cerebrospinal fluid (CSF) flows validating its use in the current application [176].   
In this investigation MRI measurements were accompanied with continuous 
relative optical measurements as well. It should however, be noted that MRI and optical 
measurements represent slightly different physiological quantities. While MR-
susceptometry measures absolute SvO2 , NIRS measures tissue oxygenation (StO2)  which 
is a weighted average of arterial and venous oxygenation levels. Additionally, optical 
measured blood flow index (BFI) is related to the motion of the moving scatterers, 
namely the red blood cells and their concentrations and is a surrogate measure of local 
cerebral blood flow.   
Figure 5.6: Plots demonstrating correlation between MR and optical measurements of changes in 
oxygenation (a) change in SvO2 vs change in StO2 and flow (b) change in SS velocity vs change in 
BFI. The dotted gray line represents the line of identity. 
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These differences withstanding the correlations between absolute SvO2 and StO2, 
and CBF and BFI were very encouraging (Figure 5.4). It is however, noted that in 
general the values of SvO2 were higher or equal to the StO2 values. Ideally, one would 
expect SvO2 values to be lower than StO2 values as the latter has an arterial contribution 
as well. This deviation from expectation could be due to measurement errors (discussed 
in the limitation section below). Also it is worth mentioning that the optical 
measurements represent the hemodynamics over a focal region under the optical probe 
(in the frontal cortex) whereas the MRI measurements represent global cortical 
oxygenation values. Some discordance between the two measurements is expected as the 
frontal areas of the brain tend to be hypometabolic in neonates and hence are known to 
have lower CBF, StO2 and CMRO2 values [177]. 
Overall, the measured CBF and CMRO2 values (Table 5.2, 5.3) were substantially 
lower than typically observed in healthy adults (~20% of the adult values; refer to 
Chapters 2, 4 & 6). Our measurements were obtained under anesthesia (fentanyl) which 
is known to decrease CBF and CMRO2 in a dose dependent manner [178]. Literature on 
cerebral hemodynamic and metabolic measurements in neonates is extremely scarce. 
However, it is noteworthy that a handful of previous studies conducted in newborns have 
also recorded low CBF and CMRO2 values [179-180]. Using PET, Altman et al. noted 
CBF and CMRO2 values between 4.7 to 17 mL/100g/min and 3.4 to 30 mol/100g/min in 
preterm infants [180]. These values are in good agreement with our measurements. 
Interestingly, CMRO2 in term newborn animals has also been shown to be lower than in 
adults, though the relationship varies with species [180-181]. The observed low oxygen 
metabolism might be due to low energy requirements in the neonatal brain. Alternatively, 
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it is plausible that the neonatal brain relies on non-oxidative pathways for energy 
production. Previous studies measuring glucose metabolism in term and preterm neonates 
have shown that cerebral glucose consumption exceeds the amount that would be 
required for purely oxidative metabolism [182-183]. Additionally, the effect of CHD 
pathology on the observed low CMRO2 measurements is also unclear.        
Further, we observed a significant correlation between baseline OEF and 
chronological age pre-operatively (p<0.0001; Figure 5.3). This has been previously 
observed and thought to be driven by a drop in hemoglobin after birth [184-185]. We did 
not observe a significant correlation between hemoglobin and chronological age; 
however, a decreasing trend was noted. Additionally, we recorded a significant increase 
in CMRO2 post-operatively compared to pre-operative levels (p=0.0156; Figure 5.2(a)). 
This is consistent with previous reports of increase in CMRO2 with chronological age, 
which may reflect increasing oxygen requirements due to synaptic development [185].  
Interestingly, the incidence of brain injury was observed to be associated with low 
absolute CMRO2 post-operatively (p=0.036; Figure 5.2 (b)). There is a paucity of 
literature investigating CMRO2 and CBF immediately following surgery. It is noteworthy 
that the few studies that have investigated the effect of a variety of surgical procedures/ 
parameters on postoperative injury have failed to find an association with the degree of 
injury or neurodevelopment outcome [156, 170, 186]. The early postoperative period is 
marked with significant hemodynamic instability and might represent a period of 
increased vulnerability to neural injury.   
 
5.5.2 Hypercapnia  
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Consistent with the known vasodilatory effect of CO2 as detailed in chapter 4, we 
observed a significant increases in CBF and SvO2 (p<0.0005; Table 5.3). Global CMRO2 
showed no population averaged changes due to hypercapnia (p=0.91; Figure 5.5), an 
observation which agrees with our previous experience in healthy adults (chapter 4) and a 
handful of publications that have studied cerebrovascular reactivity to hypercapnia in 
patients with congenital heart defects using a variety of different measurement 
techniques, including NIRS, velocity mapping MRI, ASL-pMRI, DOS and DCS [25, 187-
189]. Thus contrary to our hypothesis, increased O2 delivery as a result of hypercapnia 
was not accompanied by an increase in oxygen consumption.   
The results presented herein also demonstrate cross validation between MRI and 
optical based methods. As illustrated in Figure 5.6, we observed a significant correlation 
between MRI and optical based measurements of changes in oxygenation and CBF in 
response to hypercapnia. The average CO2 reactivity of these infants agrees well with 
previous literature values (4.4 vs 4.9 % / mm of Hg) [169]. However, it is noted that these 
values spanned a large range. Thus there exists a subset of the population with low CO2 
reactivity and hence a small cerebrovascular reserve. However, contrary to previous 
observations (Licht, Wang et al. 2004) we did not find an association between CO2 
reactivity and occurrence of pre-operative brain injury. One caveat being our small 
population of such patients (~27% had pre-operative injury). Alternatively, the injury 
suffered by our population was much less severe than that cited in previous work.  
 
5.5.3 Study Limitations 
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Even though our initial experience with the proposed MR based CMRO2 
quantification in neonates with complex CHD has been encouraging, there are some 
limitations which are worth noting. Overall our study suffers from a small sample size. 
Particularly, the post-operative measurements were obtained in only 8 subjects. 
Additionally, post-operatively, we were unable to get a blood gas on the day of the MRI 
scan (to obtain SaO2 and Hct for OEF and CMRO2 quantification) and the closest blood 
gas to the day of the post-op MRI scan was used. These numbers might thus not be truly 
representative of the exact hemodynamic state of the patient while in the MRI. However, 
for most subjects a value within two days of the MRI scan was used and should be a close 
approximation of the true value.   
The accuracy of SvO2 quantification depends on Δdo which has been previously 
determined using healthy adult blood in chapter 3. It is plausible that this constant might 
be different for fetal blood given the presence of HbF. However, we think that it is 
unlikely that the inherent paramagnetism of heme iron in its deoxy state in HbF is 
substantially different from that in HbA. Additionally, good agreement with optical data 
(Figures 5.4, 5.6) gives us additional confidence in our measurements.  
Due to difficulty in locating neck vessels in these neonates as a result of small 
caliber and tortuousity, we were unable to obtain flow measurements in the carotid and 
vertebral arteries for all subjects. However, we observed good agreement (slope = 1.02, 
R2= 0.78, p<0.005) between flow changes in response to hypercapnia within the SSS 
when compared with neck vessels in those subjects in whom we could identify such 
anatomy, justifying the use of former as a surrogate for global CBF. 
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Further, OEF, CBF and CMRO2 measurements presented herein are indicative 
only of the cortical mantle. Presently we do not have the ability to measure regional 
hemodynamic and metabolic parameters.  
 
5.6 Conclusions 
In conclusion we determined OEF, CBF and CMRO2 non-invasively in neonates with 
complex CHD pre and post-operatively and observed an association of injury with post-
operative CMRO2. Additionally we quantified mean increases in CBF and SvO2 during 
hypercapnia and report no change in CMRO2.We observed significant correlations 
between MR measured oxygenation (SvO2) and flow (CBF) parameters with optical 
measurements (StO2, BFI) both at rest and in response to hypercapnia. These results 
highlight that MRI based measurements of cerebral hemodynamics and metabolism can 
serve as a valuable adjunctive tool to evaluate and manage critically ill infants with CHD. 
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Chapter 6: Estimating Global Cerebral Oxygen Consumption in Sickle 
Cell Disease 
 
6.1 Introduction 
Sickle Cell Disease (SCD) is an autosomal recessively inherited anemia, typically 
affecting people of Afro-Caribbean and Middle Eastern origin. The primary cause for 
SCD is the inheritance of recessive hemoglobin (Hb) variant termed sickle hemoglobin 
(HbS). HbS behaves like normal hemoglobin (HbA) when fully oxygenated but at low 
oxygen tensions it polymerizes. The ensuing cycles of polymerization and 
depolymerization result in permanent crescentic deformation of the hemoglobin 
molecule. As a result, the red blood cells (RBCs) assumes a fixed elongated sickle shape, 
the corpuscular density increases and the cell becomes less pliable [190]. The rigid and 
deformed RBCs are damaged by mechanical stress as they pass through microvasculature, 
resulting in hemolytic anemia. The reduction in the volume of RBCs restricts the oxygen 
carrying capacity of blood, leading to chronic oxy-hemoglobin desaturation [191]. 
Cerebral ischemia and strokes are common in this population [192] and have been found 
to be associated with cognitive and intellectual deficits [193-194]. Although the brain has 
a high demand for oxygen and a low tolerance for deprivation, there is a paucity of 
studies investigating how this population’s cerebral hemodynamic and metabolic 
parameters are affected by their disease.  
In this study we used a previously described (chapter 2) non-invasive method for 
simultaneously measuring global cerebral venous oxygen saturation and blood flow to 
assess the cerebral health of sickle cell patients treated with or without chronic 
transfusions. The method measures venous blood oxygen saturation (SvO2) in the superior 
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sagittal sinus (SSS) via MR susceptometry, yielding intravascular bulk magnetic 
susceptibility relative to surrounding tissue, and simultaneously measures cerebral blood 
flow (CBF) in the major inflow and outflow vessels (internal carotid and vertebral 
arteries and SSS) by phase-contrast MRI.  
 
6.2 Methods 
6.2.1 Study Population 
The study was approved by Institutional Review Board of University of 
Pennsylvania and patients were recruited after informed consents were obtained from a 
parent/legal guardian or the patient if 18 years of age or older. The inclusion criteria for 
the study included a primary diagnosis of homozygous sickle cell disease (HbSS) and age 
between 12-30 years. Table 1 summarizes the characteristics of the recruited patients. 
The study population included five subjects, three of whom were receiving chronic 
transfusions.  
 
6.2.2 MR Protocol 
A modified version of the interleaved gradient-echo pulse sequence as previously 
described (chapter 2) was used for simultaneous measurement of SvO2 in the SSS and 
CBF in the SSS and neck vessels (internal carotid and vertebral arteries). Specifically, 
SvO2 was quantified using MR-susceptometry based oximetry and CBF via Phase 
Contrast MRI. These two paramters can be combined via Fick’s equation to quantify 
CMRO2. Additional details on the pulse sequence and theory behind CMRO2 
quantification can be found in chapter 2.  
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All the experiments were conducted on a 3T Tim Trio MRI system (Siemens 
Medical Systems, Malvern, NJ) using a head and neck coil. A gradient echo axial 
localizer scan was used to choose the straightest section of vessels of interest (SSS, neck 
arteries) and estimate the tilt angle θ of the SSS with respect to B0 from the coordinates of 
the centroid of the vessel (Δz ~ 4 cm ) (Langham, Magland et al. 2009). 
Scan parameters: Voxel size = 1 × 1 × 5 mm3, FOV = 176 x 176, flip angle = 25°, 
TR = 35ms, echo spacing = 6.46 ms for SvO2 quantification and voxel size = 0.65 × 0.65 
× 5 mm3, VENC = 60 (SSS) and 100 cm/s (neck) for CBF quantification, NEX = 3, total 
scan time ~ 1:20 min.  Additionally, a T1-weighted 3D magnetization-prepared rapid 
gradient-echo image dataset (voxel size = 1 x 1 x 1 mm3) was used to estimate 
intracranial volume [82]. Total brain volume was obtained using a semi-automated 
region-growing algorithm (ITKSnap) [87]. 
In two patients, the velocity measurements in the neck vessels could not be 
acquired as artifact from prior dental work obscured visualization. For consistency, flow 
measurements in the SSS were used for analysis and for the calculation of CMRO2 in 
these patients. In subjects where both neck and SSS flow measurements were acquired 
the ratio of the two measurements was used to calculate the volume of brain drained by 
the SSS; otherwise it was assumed that SSS drains 60% of the total brain volume in order 
to obtain CMRO2 measurements in units of per 100g of brain mass. 
 
6.2.3 Data Analysis 
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The SvO2 and CBF measurements were derived using the analysis techniques 
described in Chapter 2.A two sample t-test was used to investigate the effect of chronic 
transfusions on OEF, CBF and CMRO2. 
 
6.3 Results 
The characterstics of the study population and the measured hemodynamic 
parameters are summarized in Table 6.1. Average OEF , CBF and CMRO2 values in 
chronically transfused and non-transfused patients were 0.25  0.03 , 478  42 mL/min, 
101  9 mol/min/100g and 0.38  0.03, 775  40 mL/min and 128  8 mol/min/100g, 
respectively.     
 
 
 
Table 6.1: Summary table of patient characteristics and measured hemodynamic 
parameters (# DpT represents the number of days after transfusion when the MR 
measurements were acquired; Patients not on chronic transfusions are marked with 
‘X’.). 
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We observed a significantly lower OEF (p = 0.0159) and CBF (p=0.0043) (Figure 6.1) 
and a marginally lower CMRO2 (p=0.0447) in chronically transfused patients as 
compared to non-transfused patients. It is noted that most of the transfused patients had a 
history of prior cerebrovascular insults (ischemic strokes, hemorrhages etc.). 
 
6.4 Discussion and Conclusions 
The present study provides information about cerebral oxygen delivery and its 
consumption in patients with SCD. These patients are at high risk for cerebrovascular 
disease, specifically vaso-occlusion of the microvasculature and impaired tissue oxygen 
delivery.  Not surprisingly, neurological complications such as cerebral infarction and 
hemorrhagic stroke are common childhood occurrences. The Stroke Prevention Trial in 
Sickle Cell Anemia (STOP) [195] demonstrated that chronic transfusion therapy reduced 
the occurrence of stroke within this population. Candidates for transfusion were identified 
by Circle of Willis transcranial doppler ultrasonography. Patients who had already 
Figure 6.1: Box plots representing the effect of chronic transfusions on (a) oxygen extraction 
fraction (b) and blood flow in SSS.  
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experienced vaso-occlusive stroke had a decreased recurrent stroke incidence as 
compared to their non-transfused peers.  
We observed higher CBF’s and OEF’s in non-transfused as compared to 
chronically transfused patients. Higher flows in non transfused SCD patients have been 
noted before [196-197]. It is known than in SCD the degree of anemia (as is present in 
non transfused patients) increases cardiac output and hence cerebral blood flow [198-
199]. Additionally, the percent of HbSS erythorcytes, which is lowered by blood 
transfusion, is also thought to play a role in regulating blood flow.  
The observation of higher venous oxygenation values in chronically transfused 
patients (as compared to non-transfused)  also agrees well with previous observations 
[200-201]. NIRS based cerebral oximetry studies have shown that the level of 
oxygenation is positively correlated with the precent HbA from transfused RBC’s [200]. 
Interestingly, the observed SvO2 values in transfused patients were higher than typically 
noted in healthy adults. While this observation could be counfounded by a few study 
limitations (see below), increased venous oxygenation levels in the peripheral vasculature 
of SCD patients has been reported before and has been ascribed to the arterialization of 
the venous vasculature, that is, an increased amount of arterial blood bypasses the 
capillary network and gets shunted to the venous side [202]. This might be a 
protective/adaptive mechanism as higher than normal venous oxygen tensions could limit 
sickling and hence prevent vaso-occlusion. Alternately, this finding might represent the 
disruption of the capillary vasculature. Overall, the CMRO2 values in transfused patients 
were marginally lower than in non-transfused patients. This might be representative of 
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more advanced cerebrovascular pathology as most of the transfused patients in our cohort 
had previously suffered from strokes and hemorrhages. 
Even though our initial experience with using MR-susceptomtery based CMRO2 
quantification methodology looks encouraging, our current results and conclusions are 
limited by a small sample size. However the recruitment for the study is ongoing and we 
plan to enroll gender, age and race matched healthy control subjects in future to better 
understand SCD pathophysiology. In the current analysis, the total hemoglobin 
(HbA+HbS) concentration was used for calculation of CMRO2. It should however be 
noted that a fraction of HbSS is non-functional and should ideally be corrected for. This 
fraction would be larger for non-tranfused patients and might make the observed CMRO2 
differences between the two groups insignificant. Additionally, it is unclear if the 
magnetic susceptibility properties of HbS are similar to that of HbA (refer to chapter 3). 
These differences if present would effect the accuracy of our SvO2 estimates. In future we 
plan to conduct ex-vivo studies (similar to that described in chapter 3) to determine 
various constants (specifically do and oxy) needed for SvO2 quantifcation in HbS 
blood.   
In summary, we noticed that chronic red cell transfusions decreased CBF and 
OEF in patients with SCD. MR susceptometry based oximetry combined with phase 
contrast MRI may serve as a useful, non-invasive and rapid method for assessing the 
cerebral health of SCD patients. Further investigations are needed to: (a) determine if the 
magnetic susceptibility properties of HbS are similar to HbA and (b) compare the 
measured hemodynamic and metabolic parameters to healthy age, gender and race 
matched controls.   
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Chapter 7: High Temporal-Resolution In-Vivo Blood Oximetry via 
Projection Based T2 Measurement 
 
7.1 Abstract 
Measuring venous oxygen saturation (HbO2) in large blood vessels can provide important 
information about oxygen delivery and its consumption in vital organs. Quantification of 
blood’s T2 value via MR can be utilized to determine HbO2 non-invasively. We propose a 
fast method for in vivo blood T2 quantification via computing the complex difference of 
velocity-encoded projections. As blood flows continuously, its signal can be robustly 
isolated from the surrounding tissue by computing the complex difference of two central 
k-space lines with differential velocity encodings. This resultant signal can then be 
measured as a function of echo time for rapidly quantifying blood T2. We applied the 
method to quantify HbO2 in three cerebral veins at rest and in one of the veins in 
response to hypercapnia. Average HbO2 measurements in superior sagittal sinus (SSS), 
straight sinus and internal jugular vein in the group were 63 ± 3 %, 68 ± 4 % and 65 ± 
4%, respectively. Average HbO2 values in SSS during baseline, hypercapnia and 
recovery were 63.3  2.4 %, 78.6   4.7 % and 61.1  2.5 %, respectively. As compared 
to standard T2 quantification techniques, the proposed method is fast, reliable and robust 
against partial volume effects. 
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7.2 Introduction 
Since the first report by Wright et al., [46], there has been an increasing interest in 
developing faster and more robust methods to quantify the oxygenation level of blood. 
Such measurements, especially in large venous vessels, can provide valuable information 
on oxygen delivery to, and its consumption in, vital organs. Recently, several groups 
have combined this information with blood-flow measurements to obtain additional 
insights into organ oxygen energy metabolism in response to physiological challenges as 
well as in a number of pathologic conditions [12, 110, 120, 128, 203-204].  
Current intravascular MR-based methods for evaluating oxygen saturation (HbO2) 
in large blood vessels can be broadly grouped into phase-based and T2-based methods; 
both these methods are discussed in detail in chapter 1. The major strengths of phase-
based methods are their robustness, acquisition speed and temporal resolution [44]. 
However, knowledge of exact vessel orientation with respect to the main B0 field and 
suitable surrounding reference tissue are needed to accurately quantify HbO2. 
Additionally, the method is sensitive to static field inhomogeneities caused by tissue 
interfaces. For example, air-tissue interfaces in the neck make the HbO2 measurements in 
jugular vein challenging. 
T2-based methods overcome some of the above restrictions on vessel orientation 
and the need for reference tissue. These methods aim to quantify intravascular transverse 
relaxation of blood caused by protons diffusing through spatially varying magnetic field 
gradients. As discussed in chapter 1, such field gradients are created as a result of the 
frequency shifts between intra- and extra-erythrocyte spaces due to the paramagnetism of 
deoxygenated hemoglobin [51]. However, most T2 based methods are limited in their 
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application by long acquisition times and sensitivity to partial volume effects from 
surrounding tissues [46, 53, 95]. 
Here, we propose a fast method for in vivo blood T2 quantification via computing 
the complex difference of velocity-encoded projections. The proposed method is quick, 
robust and immune to tissue-induced partial-volume effects. 
 
7.3 Methods 
7.3.1 Measurement Theory 
The oxygenation dependence of T2 of blood arises due to irreversible dephasing 
of water protons as they exchange/diffuse through the magnetic field gradients induced 
by paramagnetic deoxyhemoglobin. Further details on the signal models used to describe 
transverse relaxation of blood can be found in chapter 1. 
As a modification to the standard method for T2 quantification, using a CPMG 
based T2-preparation sequence to acquire images at different echo times, we propose a 
quicker single-projection method in this investigation. As blood flows continuously, its 
signal can be robustly isolated from the surrounding tissue by computing the complex 
difference of two central k-space lines (ky=0) with different velocity encodings (VENC) 
[205]. The resultant signal can then be measured as a function of effective echo time 
(TEeff) for quantifying blood T2. The magnitude of complex difference (CD) of the signal 
with two different velocity encodings can be denoted as,  
 CD  2Z Sin v / 2VENC            [7.1] 
where Z is weighted by spin density, sequence parameters (flip angle, TE, TR) and 
relaxation times T1 and T2 and v represents the blood flow velocity. Assuming flow and 
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other sequence parameters remain constant for successive echoes, complex difference 
processing can be used to estimate T2 of the flowing spins. Signal variations due to flow 
can be minimized by choosing VENC close to the average velocity in the vessel (due to 
sinusoidal dependence of CD on velocity). 
 
7.3.2 MR protocol 
All experiments were performed on a 3T Siemens TIM Trio scanner. A flow 
phantom consisting of a vinyl tube (1.08 cm2 cross section) immersed in a cylindrical 
plastic container (10 cm diameter, 20 cm length) was constructed to mimic a blood vessel 
surrounded by tissue and compared the proposed method with conventional full k-space 
T2 measurements. The plastic container was filled with a 1.5% agarose gel mixture doped 
with 0.1mM Gd-DTPA to mimic T1 (1.28  0.04 s) and T2 (68  1.3 ms) of muscle tissue. 
The inner tube was filled with 0.1mM MnCl2 solution with relaxation properties similar 
to blood saturated to ~70%, and the tube was connected to an electrical pump. The 
solution was circulated through the phantom at a speed of 20 cm/s. The measurements 
were repeated thrice to test the reproducibility of the technique.  
 Resting-state T2 measurements were performed in eight subjects (age =27  4 
years) in the superior sagittal sinus (SSS), straight sinus (SS) and internal jugular vein 
(IJV) using the proposed method. A multi-axial localizer scan was used to select slices 
where the vessel segments were approximately straight and the direction of flow 
perpendicular to the slice orientation to ensure maximal signal and a laminar flow profile. 
The measurements in the SSS were repeated three times in each subject to test the 
reproducibility of T2 measurements in vivo. The subject was asked to rise from the 
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scanner table before being repositioned prior to each repeat scan. A cushioned head 
stabilizer was used to minimize motion and the subjects were instructed to stay alert 
during the course of the experiment as cerebral oxygenation is known to vary with the 
level of consciousness.    
Additionally, changes in blood oxygenation in response to a hypercapnia 
challenge (5% CO2) were evaluated in the SSS of five subjects. The experimental setup 
was similar to that used in a previous hypercapnia study in the authors’ laboratory [110].  
The paradigm consisted of three phases: normocapnia (baseline), hypercapnia and 
normocapnia (recovery) for durations of 3, 5, and 4 minutes, respectively. End-tidal CO2 
(EtCO2), heart rate and arterial oxygen saturation (SaO2) were monitored throughout the 
experiment using an MR-compatible physiological monitoring system (Precess, Invivo, 
Orlando, FL). Data acquisition during hypercapnia began ~2-3 minutes after the subject 
had started breathing in the gas mixture once the EtCO2 reading stabilized. This protocol 
ensured that data collection occurred during a hypercapnic steady-state.  
 
7.3.3 Sequence Design 
The sequence used for preparing T2 magnetization was similar to that used by Qin 
et al. (Qin, Grgac et al. 2011), consisting of a slice-selective saturation pulse with a 
dephasing gradient followed by a series of non-selective T2 preparation pulses (CPMG = 
10ms). Following slice-selective excitation a velocity-encoded projection (e.g. at 
+VENC) was acquired. Finally, a non-selective global saturation pulse with a dephasing 
gradient was used to reset the longitudinal magnetization and thus effectively remove any 
spin history from previous pulse sequence cycles. The above was repeated for –VENC, 
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and so forth, for each TEeff. The main difference in the present implementation is that 
instead of full k-space readout, two velocity-encoded projections were obtained for each 
TEeff.  
Sequence parameters: FOV = 176x176 mm2, number of readout points = 208, 
TEeff = 20, 40, 80 and 160 ms, VENC = 20 cm/s (SSS), 40 cm/s (SS), 15 cm/s (IJV), 45 
cm/s (SSS, hypercapnia) cm/s, nominal scan time = 1875 ms (TR) x 2 (velocity encodes) 
x4 (TEeff) s ~15s, NEX=3 (SSS), 3 (SS), 6 (IJV). It is noted that the use of composite 
pulses can lead to overestimation of T2 due to short periods in refocusing during which 
the magnetization is transiently stored on the longitudinal axis. During these periods the 
magnetization evolves with a time constant T1 instead of T2. To correct for these effects 
echo times TEcorr = 18.3, 36.6, 73.2, 146.5 msec were used for T2 fitting [206-207].  
Additionally, in order to accurately measure T2 using the proposed method it is important 
that the average flow in the vessel be similar for different TE’s. Hence a metric that 
represents the level of pulsatility in flow in the blood vessel was used to determine NEX 
(number of complex difference averages per TE). NEX was calculated using a standard 
error formula based on the mean ( ) and standard deviation ( ) of the complex 
difference of the vessel signal over several cardiac cycles (acquired using a high 
temporal-resolution velocity mapping method [208] with a temporal resolution of 20ms) 
as NEX  0.05




2 . A standard error of 5% in the T2 measurement was deemed 
acceptable. This level of error would correspond to an absolute error of ~ 4ms in T2 and 
hence 2.2% HbO2 points in blood oxygenation measurements (for a blood T2 ~ 65 ms). 
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7.3.4 Data Analysis 
Complex difference subtraction of velocity-encoded projections taken at four 
values of TE was logarithmically transformed and T2 extracted using a weighted least 
square fit. Finally, T2 measurements were converted to HbO2 values using a calibration 
equation (eqt. 2) reported previously using similar sequence parameters for a hematocrit 
(Hct) of 0.46 [207] as  
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Figure 7.1: Magnitude images of the slices used for imaging: (a) SSS; (c) SS; (e) IJV. Red 
arrow indicates the projection direction. Corresponding T2-weighted projections at TEeff= 
20, 40, 80 and 160ms (zoomed in;top to bottom, panels b, d and f).(g)The signal in (b) 
plotted against different TEcorr’s. 
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Analysis of Variance (ANOVA) was used to statistically compare the mean HbO2 values 
in the three tested cerebral veins; SSS, SS and IJV. Within subject coefficient of variation 
(CV) and intra-class correlation coefficient (ICC) were used to test reproducibility in the 
SSS. Lastly, a three-point moving average algorithm was used to plot changes in HbO2 in 
response to hypercapnia.  
 
7.4 Results 
T2 of the MnCl2 doped water (stationary) was determined to be 84.7 ms. 
Measured T2 values in the MnCl2 doped water flow phantom using conventional full k-
space and the proposed projection methods were 85.7 and 86.8 ms, respectively. 
Repeated T2 measurements in the same phantom using the projection method yielded a 
CV of 3.1%.  
The average T2 and HbO2 values in SSS, SS and IJV of all subjects were 66.5  
6.5, 76.6  8.6 and 70.2  7.2 ms, and 63.4  3.2, 68.3  4.1 and 65.2  3.7 %, 
respectively (Table 7.1). On an average HbO2 values in SSS were significantly lower 
than in the SS (p = 0.038). The mean CV and ICC of repeated HbO2 measurements in the 
SSS were 2.5% and 0.914, respectively. Average HbO2 values in SSS during baseline, 
hypercapnia and recovery were 63.3  2.4 %, 78.6   4.7 % and 61.1  2.5 %, 
respectively. A significant undershoot in HbO2 values during recovery were observed in 
two subjects (Figure 7.2). Average change in EtCO2 in response to hypercapnia was 13  
5 mm of Hg.      
 
7.5 Discussion and Conclusions 
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In this study we demonstrated a rapid, robust, noninvasive MR based method for 
estimating venous oxygen saturation via T2 mapping in large blood vessels with low flow 
pulsatility, a condition met for most cerebral veins. Additionally, we illustrated that the 
method is sensitive to physiological perturbations in oxygen saturation in response to a 
hypercapnia challenge. 
 
 
 
 
 
 
 
 
 
The main advantage of the method as compared to conventional T2 based methods is its 
speed and hence ability to obtain physiologically relevant oxygen saturation information 
with a high temporal resolution at arbitrary anatomic locations. Additionally, the method 
is robust against partial volume effects as only signal from moving blood is detected 
(complex difference).      
Figure 7.2: Time-course of HbO2 changes in SSS in response to hypercapnia (5%CO2) 
obtained at a temporal resolution of ~15 s. The shaded area represents the hypercapnic 
episode. It is noted that hypercapnia was preceded (~2-3 minutes) and followed (<1 
minute) by periods during which data acquisition was suspended. The red bars represent 
the standard error in the HbO2 measurements.  
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HbO2 was measured in three veins representing different cerebral drainage 
territories. The superior sagittal sinus receives venous drainage from superficial cortical 
veins over both cerebral hemispheres (i.e. the majority of the cerebral hemisphere’s gray 
matter mantle). In contrast, the straight sinus mostly drains the deep cerebral venous 
system as well as some areas of the upper brainstem through the confluence of the vein of 
Galen and the inferior sagittal sinus. The straight sinus then joins the superior sagittal 
sinus posteriorly at the torcula (confluence of the sinuses). This venous outflow is 
directed towards the sigmoid sinuses and finally the internal jugular veins (Schaller 
2004).  
HbO2 measurements in the SSS and IJV were found to be in good agreement with 
previous studies [42, 53, 120, 207]. To the best of our knowledge, however, this is the 
first report of HbO2 measurements in the SS. It is interesting to note variations in HbO2 
between different cerebral veins. The average HbO2 values in the SS were higher than 
those in the SSS (p=0.038). The IJV, which represents the sum of weighted venous 
outflow from SSS and SS, was observed to have HbO2 values intermediate between those 
of the SSS and SS. While we have no literature values to compare our SS measurements 
with, previous PET based studies [209-210] have shown that deep brain structures such 
as pontine nuclei, midbrain, parahippocampal gyri and thalami have significantly lower 
oxygen extraction fractions than cerebral cortices. While the reasons for such 
oxygenation differences are not well understood, it is noteworthy that these structures 
represent more conserved parts of the brain. Since these structures deal with basic 
activities needed to sustain life such as cardiovascular system control, consciousness, 
etc., it is plausible that these structures receive higher perfusion and hence have lower 
  
 
111
OEF’s as compared to more evolved structures such as cerebral cortices. Significantly 
higher perfusion in deep brain structures has also been noted in previous PET based 
studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7.1: T2 (ms; white) and HbO2 (%; grey) measurements in SSS, SS and 
IJV with the standard error in each measurement reported in brackets. 
Measurements at the SSS were repeated thrice to test measurement precision.  
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We also investigated the effect of hypercapnia on venous oxygenation. CO2 is a 
potent arteriolar vasodilator and thus increase in blood pCO2 causes a drop in vascular 
resistance and concomitant increase in cerebral blood flow [124]. Assuming that CO2 
does not alter cerebral metabolism, this increase in blood flow is accompanied by an 
increase in venous oxygenation as well. The observed changes in HbO2 in response to the 
hypercapnia challenge are in agreement with known physiological principles [12, 110, 
128] and our previous results as demonstrated in chapter 4. Interestingly, we observed a 
distinct undershoot in HbO2 upon recovery from hypercapnia in two subjects (Figure 
7.2). This phenomenon has been reported previously (chapter 4). It is noted that this 
change in HbO2 is accompanied by a change in blood flow as well and could potentially 
yield incorrect T2 values. However, our previous hypercapnia data indicates that blood 
flow velocity changes insignificantly during a single T2 measurement period and hence is 
not likely to affect the fidelity of our T2 estimates (increase in mean blood flow velocity 
in the internal carotid arteries during recovery from hypercapnia was observed to be 
~0.05cm/s2, hence the change in velocity during the15s data acquisition period will be 
<1cm/s; refer to chapter 4). Additionally, the gradual change in HbO2 during recovery 
and lack of scatter in the calculated HbO2 values as it rises towards the baseline value 
reinforces our confidence that the observation is real.    
The method has some limitations. The technique relies on a general assumption of 
constant blood flow velocity during acquisition of consecutive TEeff’s (i.e. at least over 
15s period). However, some oscillation/pulsatility in flow is always present in blood 
vessels. Pulsatility is lower in veins than in arteries and as such even lower in cerebral 
vessels. To decrease the sensitivity of the T2 measurement to flow variations, we chose a 
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VENC close to the average velocity in the vessel. Under these conditions, fluctuation in 
computed complex difference signals due to flow variations is minimized (Eq. 7.3). Also, 
signal averaging was used to reduce the effect of pulsatility in flow. Additionally, 
simulations to model the effect of flow variations on T2 values (assuming a normal 
distribution of flow velocities with a worst case scenario of 30% standard deviation about 
mean) yielded a coefficient of variation ~7 % in T2 estimates (assuming T2 = 65 ms, 
NEX=3). Typical fluctuation in complex difference signal over several cardiac cycles 
was <10% in the SS and SSS and <30% in IJV using a high temporal resolution phase-
contrast velocity mapping sequence [208]. Another pitfall of the method is that since it 
relies on projections the vessels can be spatially resolved in only one dimension. Hence, 
one needs to appropriately choose a projection direction to avoid vessel overlap. This 
constraint might be particularly challenging if trying to determine HbO2 in thoracic 
vessels. Lastly, it should be noted that HbO2 values derived from T2 measurements rely 
on empirical calibration curves that are hematocrit level specific. While it is reasonable to 
use a calibration curve pertaining to mean values in healthy adults, caution must be 
exercised in populations where variability in Hct from normal values is expected. 
Additionally, it is noted that the errors in translating T2 to HbO2 values due to differences 
(from assumed) Hct increase towards higher oxygenation values. 
In conclusion we introduced a fast, robust and reliable method to determine HbO2 
with a high temporal resolution in blood vessels with low flow pulsatility. The method 
demonstrated sensitivity to detect oxygenation differences between different cerebral 
drainage territories (cortex vs. deep brain) as well as in response to a hypercapnic 
stimulus. Potential clinical applications extend to the study of pathologic conditions 
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affecting cerebral metabolism, for example, neurodegenerative conditions such as 
Alzheimer’s dementia, Parkinson’s disease, multiple sclerosis etc. 
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Chapter 8: Conclusions and Future Work 
 
 
8.1 Conclusions 
 
Due to the fundamental relationship between brain function and oxygen 
metabolism, a robust, reliable and rapid method for quantifying CMRO2 would be of 
utility to both clinical and basic science communities. Many systemic and 
neurodegenerative disease conditions are known to effect CMRO2; absolute quantitative 
knowledge of CBF, SvO2 and CMRO2 would be useful in better understanding disease 
pathophysiology, aid in diagnosis and monitor disease progression and response to 
therapies. From a basic science perspective, measuring CMRO2 in response to 
physiological challenges as well as neuronal activation will give us deeper insights into 
routes for energy utilization and the functional architecture of the brain. 
This dissertation thesis provides a novel method for simultaneously measuring 
venous oxygen saturation and blood flow to derive CMRO2 at a high temporal resolution.  
Specifically, we explored the feasibility of using the proposed methodology for in-vivo 
CMRO2 quantification and tested the validity of underlying model assumptions. The 
proposed MR Susceptometry based oximetry for oxygenation measurements was 
evaluated against the clinically established gold standard (co-oximetry measurements) 
and was found to have excellent agreement. Further the sensitivity of the method to 
detect physiologically expected changes in response to a stimulus was evaluated by using 
a hypercapnia paradigm. In line with the known vasodilatory effect of hypercapnia, we 
observed dramatic increases in cerebral blood flow and venous oxygenation in response 
to hypercapnia. Interestingly, no change in CMRO2 was noted.  
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Further the method was translated clinically to study neonates with congenital 
heart disease and adolescents with sickle cell disease in small pilot studies. Both of these 
populations are at significant risk for cerebral ischemia, thus making quantification of 
cerebral hemodynamic and metabolic parameters valuable. In the CHD study we cross 
validated our oxygenation and flow measurements with optical measurements and found 
a significant association between post operative CMRO2 levels and incidence of brain 
injury. In the SCD study, we observed that chronic transfusion therapy was associated 
with lower cerebral blood flows and oxygen extraction fractions. Lastly we explored a 
fast T2 based method for determining the oxygen saturation of blood. The method relies 
on complex difference subtractions of velocity encoded projections and unlike 
susceptometry based oximetry is not restricted by the vessel orientation with respect to 
the main magnetic field or the need for surrounding reference tissue. We demonstrated 
sensitivity of this method to detect oxygenation differences between different cerebral 
drainage territories (cortex vs. deep brain) as well as in response to a hypercapnic 
stimulus.   
 
8.2 Future Work 
1. As pointed out in Chapters 5 and 6 our conclusions about cerebral health of patients 
with CHD and SCD are limited by small sizes and recruitment for these studies is 
ongoing.  
2.  Due to our ability to simultaneously measure flow and oxygenation, the method is 
well suited for studying dynamic neurovascular processes. The power of the method 
would benefit from higher temporal resolution (currently ~30s). Currently, we are 
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working towards this end by using key-hole imaging where only central low spatial 
frequency information is acquired in a time series scan after an initial full k-space 
acquisition. It is assumed that the high spatial frequency information is constant in time 
and does not need updating. This strategy can significantly increase the temporal 
resolution of the method (~2s) (depending on the number of k-space lines updated). 
3. A higher temporal resolution method would also facilitate measurement of 
hemodynamic and metabolic parameters in smaller cortical veins in response to task 
based stimulation analogous to fMRI experiments. This would enable better 
understanding of the biophysical mechanisms underlying the BOLD response. 
4. The method is scalable with field strength as the induced magnetization resulting from 
the blood-tissue susceptibility difference, , increases linearly with the applied magnetic 
field. Thus the method would benefit from higher SNR and spatial resolution (for above 
mentioned local/regional measurements) at higher fields (for example 7T).  
Given its high temporal resolution and robustness, I envision this method being 
used adjunctively to standard clinical brain protocols. Adding simultaneous rapid 
measurements of absolute hemodynamic and metabolic parameters to the arsenal of 
noninvasively obtainable metrics by MRI will be a big step forward in the comprehensive 
assessment of cerebral physiology and pathology.  
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